<?xml version='1.0' encoding='UTF-8'?><!DOCTYPE collection SYSTEM "BioC.dtd"><collection><source></source><date>Sat Feb 27 04:03:17 EST 2016</date><key></key>
<document><id>23382795</id><passage><infon key="DDI">No</infon><offset>0</offset><text>Blocking either nicotinic receptors (hexamethonium 200 µM) or 5-HT(3) receptors (granisetron 1 µM) together with P2 receptors had no greater effect than blocking P2 receptors alone.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="37" length="13"/><text>hexamethonium</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="81" length="11"/><text>granisetron</text></annotation></passage></document>
<document><id>22614721</id><passage><infon key="DDI">No</infon><offset>0</offset><text>Benlysta (belimumab) is a fully human recombinant monoclonal IgG antibody that neutralizes soluble B-lymphocyte stimulator and inhibits its biologic activity.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="0" length="8"/><text>benlysta</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="10" length="9"/><text>belimumab</text></annotation></passage></document>
<document><id>22961335</id><passage><infon key="DDI">No</infon><offset>0</offset><text>Peptide fusion inhibitors, such as T20 (Fuzeon, enfuvirtide) and C34, interact with the N-terminal heptad repeat of human immunodeficiency virus type 1 (HIV-1) gp41 glycoprotein to form an inactive hetero six-helix bundle (6-HB) to prevent HIV-1 infection of host cells.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="40" length="6"/><text>fuzeon</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="48" length="11"/><text>enfuvirtide</text></annotation></passage></document>
<document><id>22939974</id><passage><infon key="DDI">No</infon><offset>0</offset><text>In general, the higher dose of Mg was more effective than the lower dose in ameliorating creatine kinase-MB elevation and the state of oxidative stress, lactate accumulation, pyruvate reduction as well as preserving creatine phosphate, adenine nucleotides and Na(+),K(+)-ATPase activity.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="216" length="8"/><text>creatine</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="236" length="7"/><text>adenine</text></annotation></passage></document>
<document><id>19087331</id><passage><infon key="DDI">No</infon><offset>0</offset><text>The systematic review revealed that a 5-day course of Azithromycin with Scaling and Root Planing reduces the degree of gingival overgrowth, while a 7-day course of metronidazole is only effective on concomitant bacterial over-infection.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="53" length="12"/><text>azithromycin</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="164" length="13"/><text>metronidazole</text></annotation></passage></document>
<document><id>20502298</id><passage><infon key="DDI">No</infon><offset>0</offset><text>However, the efficacy of low molecular weight heparin plus aspirin remains unproven, highlighting the urgent need for large controlled trials.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="46" length="7"/><text>heparin</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="59" length="7"/><text>aspirin</text></annotation></passage></document>
<document><id>20212040</id><passage><infon key="DDI">No</infon><offset>0</offset><text>This SSAT1 effect cannot be attributed to the depletion of overall cellular polyamines or accumulation of N(1)-acetylspermidine (N(1)-AcSpd) because of the following: (i) addition of putrescine, spermidine, spermine, or N(1)-AcSpd did not restore the expression of GFP or GFP-eIF5A; (ii) depletion of cellular polyamines with alpha-difluoromethylornithine, an inhibitor of ornithine decarboxylase, did not inhibit exogenous gene expression; and (iii) N(1),N(11)-bis(ethyl)norspermine caused a drastic depletion of cellular polyamines through induction of endogenous SSAT1 but did not block exogenous gene expression.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="195" length="10"/><text>spermidine</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="475" length="8"/><text>spermine</text></annotation></passage></document>
<document><id>23091142</id><passage><infon key="DDI">No</infon><offset>0</offset><text>In the liver, AFB1 inhibited the activity of superoxide dismutase and glutathione peroxidase (C40 and C60; P &lt; 0.05) and increased the content of malonaldehyde (in C40 and C60), which induced the damage in the liver and kidney as shown in the photomicrographs of hematoxylin and eosin-stained sections.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="70" length="11"/><text>glutathione</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="146" length="13"/><text>malonaldehyde</text></annotation></passage></document>
<document><id>21601916</id><passage><infon key="DDI">No</infon><offset>0</offset><text>It is therefore, concluded that trypanosomosis can cause serious infertility in male red fronted gazelles and that early treatments with melarsamine hydrochloride (Cymelarsan®) at 0.3 and 0.6 mg/kg body weight or diminazene aceturate (Berenil®) at 7.0 mg/kg body weight may prevent such effects.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="213" length="10"/><text>diminazene</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="235" length="7"/><text>berenil</text></annotation></passage></document>
<document><id>20096111</id><passage><infon key="DDI">No</infon><offset>0</offset><text>Treatment of asymptomatic carriers with artemether-lumefantrine: an opportunity to reduce the burden of malaria?</text><annotation id="0"><infon key="type">DrugName</infon><location offset="40" length="10"/><text>artemether</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="51" length="12"/><text>lumefantrine</text></annotation></passage></document>
<document><id>21682350</id><passage><infon key="DDI">No</infon><offset>0</offset><text>BACKGROUND: In virologically suppressed patients, switching to darunavir/ritonavir (DRV/r) monotherapy maintains HIV RNA suppression, and could also lower treatment costs.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="63" length="9"/><text>darunavir</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="73" length="9"/><text>ritonavir</text></annotation></passage></document>
<document><id>22629261</id><passage><infon key="DDI">No</infon><offset>0</offset><text>The metabolite changes observed in PHYAOX leaves, together with those in the source leaves, identified possible candidates for the metabolite signature (e.g., 2-oxo-glutarate, spermidine, putrescine, 4-amino-butyrate, and tryptophan) during short-day-induced growth cessation in aspen leaves.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="176" length="10"/><text>spermidine</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="188" length="10"/><text>putrescine</text></annotation></passage></document>
<document><id>23229850</id><passage><infon key="DDI">No</infon><offset>0</offset><text>Similarly, the average tramadol consumption at hours 24 and 48 was significantly lower for the cholestyramine group (5.32 ± 21.45 vs. 43.18 ± 61.56 mg at 24 h, and 4.48 ± 16.65 vs. 57.63 ± 65.47 mg at 48 h; P &lt; 0.001).</text><annotation id="0"><infon key="type">DrugName</infon><location offset="23" length="8"/><text>tramadol</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="95" length="14"/><text>cholestyramine</text></annotation></passage></document>
<document><id>21404858</id><passage><infon key="DDI">No</infon><offset>0</offset><text>Because of its ability to kill flies sooner after it is exposed to flies when food is present or absent, thiamethoxam or imidacloprid in sucrose or Nu-Lure bait may reduce infestations in cherries more than spinosad bait when mature R. indifferens are present in orchards.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="137" length="7"/><text>sucrose</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="207" length="8"/><text>spinosad</text></annotation></passage></document>
<document><id>21517652</id><passage><infon key="DDI">No</infon><offset>0</offset><text>In cost-effectiveness analyses, compared with enoxaparin, rivaroxaban showed the potential to reduce costs associated with the prophylaxis and treatment of thromboembolic events in a post-orthopedic surgery/arthroplasty population.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="46" length="10"/><text>enoxaparin</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="58" length="11"/><text>rivaroxaban</text></annotation></passage></document>
<document><id>22411533</id><passage><infon key="DDI">No</infon><offset>0</offset><text>One of the compounds (itraconazole) had a recovery lower than 10 % and nystatin was not detected.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="22" length="12"/><text>itraconazole</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="71" length="8"/><text>nystatin</text></annotation></passage></document>
<document><id>19071043</id><passage><infon key="DDI">No</infon><offset>0</offset><text>Lynxes captured in the wild had higher concentrations of iron, calcium, alkaline phosphatase and creatinine, but lower aspartate aminotransferase and alanine aminotransferase than lynxes maintained in captivity.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="63" length="7"/><text>calcium</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="72" length="20"/><text>alkaline phosphatase</text></annotation></passage></document>
<document><id>22550577</id><passage><infon key="DDI">No</infon><offset>0</offset><text>This subgroup analysis assessed the efficacy of duloxetine in patients with chronic low back pain (CLBP) who did or did not use concomitant nonsteroidal anti-inflammatory drugs (NSAIDs) or acetaminophen (APAP).</text><annotation id="0"><infon key="type">DrugName</infon><location offset="48" length="10"/><text>duloxetine</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="189" length="13"/><text>acetaminophen</text></annotation></passage></document>
<document><id>20396748</id><passage><infon key="DDI">No</infon><offset>0</offset><text>These changes were accompanied by a decrease in the concentration of copper and increase in the contents of iron and zinc.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="108" length="4"/><text>iron</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="117" length="4"/><text>zinc</text></annotation></passage></document>
<document><id>23201399</id><passage><infon key="DDI">No</infon><offset>0</offset><text>Routine daily bathing of intensive care (ICU) patients with topical chlorhexidine reduces meticillin-resistant Staphylococcus aureus (MRSA) acquisition.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="68" length="13"/><text>chlorhexidine</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="90" length="10"/><text>meticillin</text></annotation></passage></document>
<document><id>20015890</id><passage><infon key="DDI">No</infon><offset>0</offset><text>Erythroid stimulating agents had been or were being used in 36.8% of the lower risk patients, iron chelation in 31% of lower risk patients requiring red blood cell transfusions and lenalidomide in 41% of lower risk patients with del 5q.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="94" length="4"/><text>iron</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="181" length="12"/><text>lenalidomide</text></annotation></passage></document>
<document><id>21403842</id><passage><infon key="DDI">No</infon><offset>0</offset><text>Collectively, these results show that administration of macitentan in combination with paclitaxel prevents the progression of ovarian cancer in the peritoneal cavity of nude mice in part by inhibiting survival pathways of both tumor cells and tumor-associated endothelial cells.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="56" length="10"/><text>macitentan</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="87" length="10"/><text>paclitaxel</text></annotation></passage></document>
<document><id>22126687</id><passage><infon key="DDI">No</infon><offset>0</offset><text>Similarly, areas under the plasma acetaminophen concentration-time curves for the first 60, 90, 120, and 240 minutes after administration were significantly lower for atropine versus metoclopramide or control treatment, whereas differences between metoclopramide and control treatments were not identified.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="167" length="8"/><text>atropine</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="248" length="14"/><text>metoclopramide</text></annotation></passage></document>
<document><id>20200576</id><passage><infon key="DDI">No</infon><offset>0</offset><text>Static formalin baths of 170 ppm (37% formaldehyde) for 1 hour, supplemented with oxygen, may reduce amoebic infections but should be used cautiously as treatment can precipitate mortality in fish with gill disease.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="7" length="8"/><text>formalin</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="38" length="12"/><text>formaldehyde</text></annotation></passage></document>
<document><id>22834106</id><passage><infon key="DDI">No</infon><offset>0</offset><text>GSK-3beta codes for an enzyme which is a target for the action of mood stabilizers, lithium and possibly of valproic acid.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="84" length="7"/><text>lithium</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="108" length="8"/><text>valproic</text></annotation></passage></document>
<document><id>23149557</id><passage><infon key="DDI">No</infon><offset>0</offset><text>Our previous studies provided evidence that the BBB Na-K-Cl cotransporter is stimulated by the ischemic factors hypoxia, aglycemia, and arginine vasopressin (AVP), and that inhibition of the cotransporter by intravenous bumetanide greatly reduces edema and infarct in rats subjected to permanent middle cerebral artery occlusion (pMCAO).</text><annotation id="0"><infon key="type">DrugName</infon><location offset="145" length="11"/><text>vasopressin</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="220" length="10"/><text>bumetanide</text></annotation></passage></document>
<document><id>19576883</id><passage><infon key="DDI">No</infon><offset>0</offset><text>In the isolated aorta rings, vasodilator responses to nitroglycerin were reduced in the presence of ethacrynic acid or cyanamide while the inhibitory effect of cyanamide was more profound.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="119" length="9"/><text>cyanamide</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="100" length="15"/><text>ethacrynic acid</text></annotation></passage></document>
<document><id>20833794</id><passage><infon key="DDI">No</infon><offset>0</offset><text>Here, we compared sulfasalazine and a novel EP4 agonist for their abilities to prevent colitis induction and relieve symptoms of established colitis in a dextran sulfate sodium-indomethacin mouse model.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="18" length="13"/><text>sulfasalazine</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="177" length="12"/><text>indomethacin</text></annotation></passage></document>
<document><id>23441978</id><passage><infon key="DDI">No</infon><offset>0</offset><text>Darunavir/ritonavir can be co-administered with artemether/lumefantrine without dose adjustment but should be used with caution.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="48" length="10"/><text>artemether</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="59" length="12"/><text>lumefantrine</text></annotation></passage></document>
<document><id>23018582</id><passage><infon key="DDI">No</infon><offset>0</offset><text>CONCLUSIONS: The study suggested that quetiapine use may be associated with a moderately lower risk of cerebrovascular events than olanzapine in older adults.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="38" length="10"/><text>quetiapine</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="131" length="10"/><text>olanzapine</text></annotation></passage></document>
<document><id>21352389</id><passage><infon key="DDI">No</infon><offset>0</offset><text>The main results were: (1) an association of slow-wave sleep with verbal memory performance at baseline; (2) a suppression of REM sleep in patients taking citalopram and reboxetine; (3) no differences regarding neuropsychological performance within the treatment groups; and (4) no association of REM sleep diminution with decreases in memory performance or cognitive flexibility in patients treated with citalopram or reboxetine.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="405" length="10"/><text>citalopram</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="419" length="10"/><text>reboxetine</text></annotation></passage></document>
<document><id>22302733</id><passage><infon key="DDI">No</infon><offset>0</offset><text>Comparison with the results obtained for the 1990-1995 period showed a lower peritonitis rate, a strong decline in the proportion of Staphylococcus aureus episodes, a significant increase in the frequency of oxacillin-resistant CoNS and amikacin-resistant NFGNB, and a significantly lower resolution and higher death rate.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="208" length="9"/><text>oxacillin</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="237" length="8"/><text>amikacin</text></annotation></passage></document>
<document><id>21512445</id><passage><infon key="DDI">No</infon><offset>0</offset><text>In this study, we found that salidroside could attenuate hydrogen peroxide (H(2)O(2))-induced HL-7702 cell damage, inhibit H(2)O(2)-induced cytosolic free Ca2+ ([Ca2+]i) elevation, scavenge reactive oxygen species (ROS) and increase 3'-5'-cyclic adenosine monophosphate (cAMP) level in a dose-dependent manner, but it couldn't influence 3'-5'-cyclic guanosine monophosphate (cGMP) levels.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="246" length="9"/><text>adenosine</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="350" length="9"/><text>guanosine</text></annotation></passage></document>
<document><id>21516744</id><passage><infon key="DDI">No</infon><offset>0</offset><text>There is evidence for the successful use of simvastatin (zocor) in combined therapy with fibrates, nicotinic acid, and ezetrol.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="57" length="5"/><text>zocor</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="119" length="7"/><text>ezetrol</text></annotation></passage></document>
<document><id>20448062</id><passage><infon key="DDI">No</infon><offset>0</offset><text>Organisms in the lower tract can be eliminated by treating mice with a tetracycline, or progesterone or by natural resolution.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="71" length="12"/><text>tetracycline</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="88" length="12"/><text>progesterone</text></annotation></passage></document>
<document><id>23086647</id><passage><infon key="DDI">No</infon><offset>0</offset><text>CONCLUSION: The expression of RRMI and ERCC1 genes in tumor tissues and RRM1 in peripheral blood lymphocytes is closely correlated with the response to chemotherapy and prognosis of patients with advanced NSCLC treated with gemcitabine plus carboplatin.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="224" length="11"/><text>gemcitabine</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="241" length="11"/><text>carboplatin</text></annotation></passage></document>
<document><id>21062755</id><passage><infon key="DDI">No</infon><offset>0</offset><text>CONCLUSIONS: The study provides further evidence for the activity of gemcitabine plus oxaliplatin combination as a first-line treatment for advanced biliary tract carcinomas.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="69" length="11"/><text>gemcitabine</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="86" length="11"/><text>oxaliplatin</text></annotation></passage></document>
<document><id>22431070</id><passage><infon key="DDI">No</infon><offset>0</offset><text>Extracts, orlistat or only ethanol were given orally to the rats together with the test meal and the rate of increase of postprandial triglycerides was assessed over 4?h.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="10" length="8"/><text>orlistat</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="27" length="7"/><text>ethanol</text></annotation></passage></document>
<document><id>19076573</id><passage><infon key="DDI">No</infon><offset>0</offset><text>CONCLUSION: The concomitant use of dexmedetomidine in patients undergoing spinal fusion reduces propofol infusion requirements when compared with those patients receiving only propofol and remifentanil.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="176" length="8"/><text>propofol</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="189" length="12"/><text>remifentanil</text></annotation></passage></document>
<document><id>19869386</id><passage><infon key="DDI">No</infon><offset>0</offset><text>6. It is possible by the combined use of adequate amounts of magnesium sulfate and of heparin intravenously to prevent all stages of thrombus formation for from 1 to 3 hours.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="61" length="9"/><text>magnesium</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="86" length="7"/><text>heparin</text></annotation></passage></document>
<document><id>19811859</id><passage><infon key="DDI">No</infon><offset>0</offset><text>Interestingly amodiaquine, together with some synthesised derivatives (11, 12, 15, 27, 34), displayed antileishmanial activity in the low micromolar range, although these compounds were also cytotoxic and have a narrow therapeutic window, most of the synthesised compounds proved to be potent antimalarials, a few of them showing a good activity against the chloroquine resistant K1 strain.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="14" length="11"/><text>amodiaquine</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="358" length="11"/><text>chloroquine</text></annotation></passage></document>
<document><id>22389921</id><passage><infon key="DDI">No</infon><offset>0</offset><text>After a heart attack six years ago, I went on Lipitor (atorvastatin) because my doctor said it was proven to reduce the risk of a second heart attack in high-risk people like me.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="46" length="7"/><text>lipitor</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="55" length="12"/><text>atorvastatin</text></annotation></passage></document>
<document><id>22025372</id><passage><infon key="DDI">No</infon><offset>0</offset><text>Chlorthalidone (CTD) reduces 24-hour blood pressure more effectively than hydrochlorothiazide (HCTZ), but whether this influences electrocardiographic left ventricular hypertrophy is uncertain.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="0" length="14"/><text>chlorthalidone</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="74" length="19"/><text>hydrochlorothiazide</text></annotation></passage></document>
<document><id>22291396</id><passage><infon key="DDI">No</infon><offset>0</offset><text>We assessed the effect of oestradiol treatment in women on the endocrine responses to the 5-hydroxytryptamine (5-HT) precursor, L-tryptophan (LTP) (5 g i.v.) and the dopamine agonist, apomorphine (0.005 mg/kg s.c.).</text><annotation id="0"><infon key="type">DrugName</infon><location offset="166" length="8"/><text>dopamine</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="184" length="11"/><text>apomorphine</text></annotation></passage></document>
<document><id>21338669</id><passage><infon key="DDI">No</infon><offset>0</offset><text>Men taking valproic acid have significantly higher dehydroepiandrosterone levels and lower gonadotropin concentration.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="11" length="13"/><text>valproic acid</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="51" length="22"/><text>dehydroepiandrosterone</text></annotation></passage></document>
<document><id>22415638</id><passage><infon key="DDI">No</infon><offset>0</offset><text>The literature on combinations with clozapine as a means to enhance efficacy and with aripiprazole to reduce side effects was reviewed.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="36" length="9"/><text>clozapine</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="86" length="12"/><text>aripiprazole</text></annotation></passage></document>
<document><id>20052976</id><passage><infon key="DDI">No</infon><offset>0</offset><text>This parasite relies on inosine 5'-monophosphate dehydrogenase (IMPDH) to obtain guanine nucleotides, and inhibition of this enzyme blocks parasite proliferation.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="24" length="7"/><text>inosine</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="81" length="7"/><text>guanine</text></annotation></passage></document>
<document><id>19637104</id><passage><infon key="DDI">No</infon><offset>0</offset><text>CONCLUSION: These results indicate that a single dose of zonisamide reduces urge to drink and the quantity of ethanol self-administered by risky drinkers during their second hour of access to alcohol.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="57" length="10"/><text>zonisamide</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="110" length="7"/><text>ethanol</text></annotation></passage></document>
<document><id>21091846</id><passage><infon key="DDI">No</infon><offset>0</offset><text>Therefore, a number of randomized clinical trials (RCT) were conducted in the 1990s to investigate the efficacy of CAB with an antiandrogen (nilutamide or flutamide) plus castration; however, there were both positive and negative results for the efficacy of CAB.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="141" length="10"/><text>nilutamide</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="155" length="9"/><text>flutamide</text></annotation></passage></document>
<document><id>23320823</id><passage><infon key="DDI">No</infon><offset>0</offset><text>RESULTS: We measured vascular responses to acetylcholine (ACh) and sodium nitroprusside (SNP) of isolated coronary arteries from SMP30 KO and wild-type (WT) mice.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="43" length="13"/><text>acetylcholine</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="74" length="13"/><text>nitroprusside</text></annotation></passage></document>
<document><id>20237017</id><passage><infon key="DDI">No</infon><offset>0</offset><text>Here, we show that mn1-1 basal kernel regions (pedicels and basal endosperm transfer layer) accumulate higher levels of sucrose and lower levels of glucose and fructose between 8 and 28 d after pollination when compared with the wild type, whereas upper regions of mn1 accumulate similar or increased concentrations of sugars.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="120" length="7"/><text>sucrose</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="160" length="8"/><text>fructose</text></annotation></passage></document>
<document><id>23331485</id><passage><infon key="DDI">No</infon><offset>0</offset><text>CONCLUSION: The COX inhibitors indomethacin and celecoxib reduce the expression of inflammatory factors, such as COX-2 and IL-6, in FLS from the TMJ via suppression of PGE2 production.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="31" length="12"/><text>indomethacin</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="48" length="9"/><text>celecoxib</text></annotation></passage></document>
<document><id>21708236</id><passage><infon key="DDI">No</infon><offset>0</offset><text>Tetracycline, loaded as free drug into the film together with alendronate-LDH clay complex released more rapidly than alendronate, but showed evidence of intercalation in the LDH clay particles.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="0" length="12"/><text>tetracycline</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="118" length="11"/><text>alendronate</text></annotation></passage></document>
<document><id>19628292</id><passage><infon key="DDI">No</infon><offset>0</offset><text>CONCLUSION: Overall, Lipoplatin appears to have lower toxicity, mainly renal toxicity as well as higher efficacy than cisplatin when combined with gemcitabine in advanced NSCLC.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="118" length="9"/><text>cisplatin</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="147" length="11"/><text>gemcitabine</text></annotation></passage></document>
<document><id>20800407</id><passage><infon key="DDI">No</infon><offset>0</offset><text>BACKGROUND: Ticlopidine/clopidogrel prevents major adverse cardiac events after PCI, but no trials have shown an effect on mortality.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="12" length="11"/><text>ticlopidine</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="24" length="11"/><text>clopidogrel</text></annotation></passage></document>
<document><id>21507837</id><passage><infon key="DDI">No</infon><offset>0</offset><text>This suggests the SJS was initially caused by furosemide, a nonaromatic sulfonamide diuretic, with slow progression prior to hospital admission over approximately 7 weeks, followed by an acute worsening caused by lincomycin, a sulfide antibiotic.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="46" length="10"/><text>furosemide</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="213" length="10"/><text>lincomycin</text></annotation></passage></document>
<document><id>20504437</id><passage><infon key="DDI">No</infon><offset>0</offset><text>Phenobarbital showed no effect, and thiopental inhibition was &lt;30% of the DNA synthesis in control condition with all cell lines used at the concentration of 0.4 mM.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="0" length="13"/><text>phenobarbital</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="36" length="10"/><text>thiopental</text></annotation></passage></document>
<document><id>20641197</id><passage><infon key="DDI">No</infon><offset>0</offset><text>Because of their role in the development of different neoplasms, small-molecule drugs such as imatinib, dasatinib, and others that block TK activity by inhibiting ATP binding to the enzyme are often used to treat patients suffering from this disease (3, 4).</text><annotation id="0"><infon key="type">DrugName</infon><location offset="94" length="8"/><text>imatinib</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="104" length="9"/><text>dasatinib</text></annotation></passage></document>
<document><id>19664617</id><passage><infon key="DDI">No</infon><offset>0</offset><text>In addition, a significant reduction in activities of myocardial creatine kinase-MB (CK-MB) isoenzyme, lactate dehydrogenase (LDH), superoxide dismutase (SOD), catalase, and reduced glutathione (GSH) level along with increase in malondialdehyde (MDA) content were observed.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="65" length="8"/><text>creatine</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="182" length="11"/><text>glutathione</text></annotation></passage></document>
<document><id>22661646</id><passage><infon key="DDI">No</infon><offset>0</offset><text>OBJECTIVES: Evaluate the efficacy of intravenous golimumab 2 mg/kg+methotrexate (MTX) in patients with active rheumatoid arthritis (RA) receiving MTX.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="49" length="9"/><text>golimumab</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="67" length="12"/><text>methotrexate</text></annotation></passage></document>
<document><id>21947296</id><passage><infon key="DDI">No</infon><offset>0</offset><text>Using myography, arteries from NBCn1 knockout mice showed reduced acetylcholine-induced NO-mediated relaxations and lower rho-kinase-dependent norepinephrine-stimulated smooth muscle Ca²? sensitivity.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="66" length="13"/><text>acetylcholine</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="143" length="14"/><text>norepinephrine</text></annotation></passage></document>
<document><id>21701644</id><passage><infon key="DDI">No</infon><offset>0</offset><text>Nifedipine Ca(2+) responses were dose-dependently blocked by NPS2390 and by the same inhibitors of PLC, IP(3) receptors, and NSCCs that disrupted the action of gentamicin.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="0" length="10"/><text>nifedipine</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="160" length="10"/><text>gentamicin</text></annotation></passage></document>
<document><id>19537840</id><passage><infon key="DDI">No</infon><offset>0</offset><text>In the LIFE study, losartan-based therapy was associated with a lower incidence of cardiovascular morbidity and mortality than atenolol-based therapy, mainly as a result of a reduced risk of stroke; the incidence of new-onset diabetes mellitus was also lower with losartan-based therapy.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="127" length="8"/><text>atenolol</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="264" length="8"/><text>losartan</text></annotation></passage></document>
<document><id>21925256</id><passage><infon key="DDI">No</infon><offset>0</offset><text>RESULTS: Andrographolide (1, 10, 100 µM) significantly down-regulates the mRNA level and protein level of CYP3A4, and inhibits nifedipine oxidation and testosterone 6ß-hydroxylation.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="127" length="10"/><text>nifedipine</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="152" length="12"/><text>testosterone</text></annotation></passage></document>
<document><id>22827228</id><passage><infon key="DDI">No</infon><offset>0</offset><text>Results: (1) tear ECP levels were significantly higher in VKC patients than in healthy controls; (2) tear ECP levels showed a significant correlation to signs (p &lt;0.005) and symptoms (p &lt;0.001) of the disease; (3) tear ECP was reduced by both 2% cyclosporine and 0.1% dexamethasone; (4) tear and plasma histaminase activity, measured by the ratio of histamine in treated to untreated samples, were significantly lower in VKC patients compared to controls (p &lt;0.0001 and p &lt;0.001, respectively).</text><annotation id="0"><infon key="type">DrugName</infon><location offset="246" length="12"/><text>cyclosporine</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="268" length="13"/><text>dexamethasone</text></annotation></passage></document>
<document><id>19683284</id><passage><infon key="DDI">No</infon><offset>0</offset><text>CONCLUSIONS: These data suggest that the risks of recurrence and progression to surgery after bacillus Calmette-Guerin are higher in patients on warfarin, while the risk of progression is lower in patients on aspirin.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="145" length="8"/><text>warfarin</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="209" length="7"/><text>aspirin</text></annotation></passage></document>
<document><id>20530581</id><passage><infon key="DDI">No</infon><offset>0</offset><text>This report establishes a requirement for the transcription repressor PR domain zinc finger protein 1 (PRDM1, Blimp1) in the response to bortezomib.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="70" length="31"/><text>PR domain zinc finger protein 1</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="137" length="10"/><text>bortezomib</text></annotation></passage></document>
<document><id>20042098</id><passage><infon key="DDI">No</infon><offset>0</offset><text>Anti-histamines, especially promethazine, were routinely co-administered with chloroquine at this period too.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="28" length="12"/><text>promethazine</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="78" length="11"/><text>chloroquine</text></annotation></passage></document>
<document><id>22092298</id><passage><infon key="DDI">No</infon><offset>0</offset><text>In plasma, compared with those maintained on buprenorphine, the methadone-maintained subjects had increased codeine and norcodeine concentrations (P &lt; 0.004), similar morphine (P= 0.72) and lower morphine-3- and -6- and codeine-6-glucuronide concentrations (P &lt; 0.008).</text><annotation id="0"><infon key="type">DrugName</infon><location offset="196" length="8"/><text>morphine</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="220" length="7"/><text>codeine</text></annotation></passage></document>
<document><id>20516285</id><passage><infon key="DDI">No</infon><offset>0</offset><text>Using previously published data on the in vitro activities of chloroquine, lumefantrine, piperaquine, and dihydroartemisinin, we investigated the association of their activities with pfnhe polymorphism.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="62" length="11"/><text>chloroquine</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="75" length="12"/><text>lumefantrine</text></annotation></passage></document>
<document><id>20927740</id><passage><infon key="DDI">No</infon><offset>0</offset><text>Combined dexamethasone and epinephrine may reduce outpatient admissions, but results are exploratory and safety data limited.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="9" length="13"/><text>dexamethasone</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="27" length="11"/><text>epinephrine</text></annotation></passage></document>
<document><id>23106234</id><passage><infon key="DDI">No</infon><offset>0</offset><text>The addition of melatonin also controlled the burst of hydrogen peroxide, possibly through direct scavenging and by enhancing the activities of antioxidative enzymes and the capacity of the ascorbate-glutathione cycle.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="16" length="9"/><text>melatonin</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="200" length="11"/><text>glutathione</text></annotation></passage></document>
<document><id>20926642</id><passage><infon key="DDI">No</infon><offset>0</offset><text>CONCLUSION: As the increase of choline, creatine and myo-inositol are usually interpreted to indicate glial activation and macrophage infiltration in chronic inflammation and slow virus infections of the brain the present data endorse the hypothesis, that HCV infection may induce neuroinflammation and brain dysfunction.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="31" length="7"/><text>choline</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="40" length="8"/><text>creatine</text></annotation></passage></document>
<document><id>23022430</id><passage><infon key="DDI">No</infon><offset>0</offset><text>Emerging evidence shows that the most common treatment of ADHD with the dopamine agonist and psychostimulant Methylphenidate attenuates most timing deficits in ADHD and normalises the abnormally blunted recruitment of the underlying fronto-striato-cerebellar networks.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="72" length="8"/><text>dopamine</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="109" length="15"/><text>methylphenidate</text></annotation></passage></document>
<document><id>19184650</id><passage><infon key="DDI">No</infon><offset>0</offset><text>In this chapter, we briefly overview the fundamental characteristics of nAChRs that are germane to nicotine's effects and then consider the cellular responses to acute and chronic nicotine, with particular emphasis on dopamine systems because they have been the most widely studied in the context of nicotine dependence.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="300" length="8"/><text>nicotine</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="218" length="8"/><text>dopamine</text></annotation></passage></document>
<document><id>20303077</id><passage><infon key="DDI">No</infon><offset>0</offset><text>By contrast, aminopenicillins were more effective in enterococci from pig manure, and mean MIC-values of piperacillin+tazobactam and third generation cefalosporines were significantly lower in E. coli from pig manure than in E. coli from sewage sludge.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="105" length="12"/><text>piperacillin</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="118" length="10"/><text>tazobactam</text></annotation></passage></document>
<document><id>20273308</id><passage><infon key="DDI">No</infon><offset>0</offset><text>Comparative activities of amethocaine, cinchocaine and procaine as local anaesthetics.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="39" length="11"/><text>cinchocaine</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="55" length="8"/><text>procaine</text></annotation></passage></document>
<document><id>22153532</id><passage><infon key="DDI">No</infon><offset>0</offset><text>Ascorbic acid prevented the decreased response to acetylcholine after glucose, the response to nitroprusside was unaffected by ascorbic acid.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="50" length="13"/><text>acetylcholine</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="95" length="13"/><text>nitroprusside</text></annotation></passage></document>
<document><id>21245559</id><passage><infon key="DDI">No</infon><offset>0</offset><text>These results indicate that degradation of base-extractable EPS accounts for the lower sludge yield in AS+ASSR, and based on the literature this organic pool is believed to be aluminium and/or iron-bound EPS.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="176" length="9"/><text>aluminium</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="193" length="4"/><text>iron</text></annotation></passage></document>
<document><id>23370365</id><passage><infon key="DDI">No</infon><offset>0</offset><text>CONCLUSION: The recommended phase II dose of capecitabine is 3500 mg when given concurrently with 50.4 Gy of thoracic radiotherapy in 28 fractions and weekly docetaxel.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="45" length="12"/><text>capecitabine</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="158" length="9"/><text>docetaxel</text></annotation></passage></document>
<document><id>22785204</id><passage><infon key="DDI">No</infon><offset>0</offset><text>These studies demonstrate the limitations of using HNSCC cell lines to reflect the heterogeneous clinical responses to erlotinib and cetuximab, and suggest that different approaches including heterotopic tumorgrafts may prove more valuable to elucidate mechanisms of clinical resistance to EGFR inhibitors in HNSCC.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="119" length="9"/><text>erlotinib</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="133" length="9"/><text>cetuximab</text></annotation></passage></document>
<document><id>21821971</id><passage><infon key="DDI">No</infon><offset>0</offset><text>We examined the effects of PPIs [omeprazole (OPZ) and rabeprazole (RPZ)] on TCL metabolism using pooled human liver microsomes prepared from various human liver blocks and 12 individual human liver microsomes.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="33" length="10"/><text>omeprazole</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="54" length="11"/><text>rabeprazole</text></annotation></passage></document>
<document><id>20204432</id><passage><infon key="DDI">No</infon><offset>0</offset><text>After ESI-MS and NMR characterization this building block was used for the assembly of a thymine-functionalized tetrapeptide, composed of 4-piperidinyl glycine and L-arginine moieties alternated in the backbone.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="89" length="7"/><text>thymine</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="152" length="7"/><text>glycine</text></annotation></passage></document>
<document><id>21527371</id><passage><infon key="DDI">No</infon><offset>0</offset><text>We conducted a prospective single-centre study to determine the efficacy of pulsed intravenous methylprednisolone followed by a short reducing course of oral prednisolone in ten patients with confirmed DRESS.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="95" length="18"/><text>methylprednisolone</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="158" length="12"/><text>prednisolone</text></annotation></passage></document>
<document><id>22349746</id><passage><infon key="DDI">No</infon><offset>0</offset><text>CONCLUSION: Our data suggest that the administration of IV paracetamol decreases propofol-ketamine consumption for adequate sedation during ESWL procedures in paediatric patients and shortens recovery time.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="81" length="8"/><text>propofol</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="90" length="8"/><text>ketamine</text></annotation></passage></document>
<document><id>21679467</id><passage><infon key="DDI">No</infon><offset>0</offset><text>Established AKI patients had lower SBP, higher heart rate, and higher epinephrine excretion than healthy controls, though aldosterone excretion was not different.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="70" length="11"/><text>epinephrine</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="122" length="11"/><text>aldosterone</text></annotation></passage></document>
<document><id>23393346</id><passage><infon key="DDI">No</infon><offset>0</offset><text>Chemosensitivity testing revealed that sensitivity of COX-2 transfectants to 5-fluorouracil and cisplatin was significantly lower than in control vector-only transfectants, and that sensitivity of COX-2 transfectants was restored by the transfection of COX-2-specific siRNA.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="79" length="12"/><text>fluorouracil</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="96" length="9"/><text>cisplatin</text></annotation></passage></document>
<document><id>22552360</id><passage><infon key="DDI">No</infon><offset>0</offset><text>On the other hand, several non-Japanese studies have shown the efficacy of capecitabine plus cisplatin (XP), which has been used as the reference arm in recent global studies of AGC.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="75" length="12"/><text>capecitabine</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="93" length="9"/><text>cisplatin</text></annotation></passage></document>
<document><id>21069429</id><passage><infon key="DDI">No</infon><offset>0</offset><text>Although cisplatin is related to severe colonic cytotoxicity, it has not been previously reported that capecitabine induces arterial thrombosis and necrosis of the gastrointestinal mucosa and inhibits angiogenesis.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="9" length="9"/><text>cisplatin</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="103" length="12"/><text>capecitabine</text></annotation></passage></document>
<document><id>20206067</id><passage><infon key="DDI">No</infon><offset>0</offset><text>However, two recently completed clinical trials indicate that neither atorvastatin nor simvastatin slow the progression of early Alzheimer&amp;apos;s disease.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="70" length="12"/><text>atorvastatin</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="87" length="11"/><text>simvastatin</text></annotation></passage></document>
<document><id>23319542</id><passage><infon key="DDI">No</infon><offset>0</offset><text>Compared with normP, 16-keto-estradiol-17ß levels were significantly higher in sPE, whereas 16-epi-estriol and 17-epi-estriol were lower in women with sPE.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="29" length="9"/><text>estradiol</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="118" length="7"/><text>estriol</text></annotation></passage></document>
<document><id>21845061</id><passage><infon key="DDI">No</infon><offset>0</offset><text>The aim of this study was to evaluate the effect of hepatic iron concentration (HIC) and viral factors on the sustained virological response (SVR) in chronic HCV-infected patients, with beta thalassemia major being treated with interferon and ribavirin.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="60" length="4"/><text>iron</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="243" length="9"/><text>ribavirin</text></annotation></passage></document>
<document><id>21599629</id><passage><infon key="DDI">No</infon><offset>0</offset><text>Furthermore, bevacizumab, an inhibitor of vascular endothelial growth factor (VEGF), sunitinib, a multiple kinase inhibitor that blocks several receptor tyrosine kinases, and sorafenib (BAY 43-9006), a multiple kinase inhibitor that blocks not only receptor tyrosine kinases but also serine/threonine kinases along the RAS/RAF/MEK/ERK pathway, were studied, as well.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="85" length="9"/><text>sunitinib</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="175" length="9"/><text>sorafenib</text></annotation></passage></document>
<document><id>20602334</id><passage><infon key="DDI">No</infon><offset>0</offset><text>The minimal inhibitory concentration (MIC) of caspofungin and amphotericin B was two-fold lower for sec59-1 and dpm1-6 than for the respective wild-type strains.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="46" length="11"/><text>caspofungin</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="62" length="12"/><text>amphotericin</text></annotation></passage></document>
<document><id>22868059</id><passage><infon key="DDI">No</infon><offset>0</offset><text>At week 12, further decreases in YMRS and MADRS total scores were observed with asenapine (YMRS: -22.4; MADRS: -11.9); non-statistically different from olanzapine (YMRS: -20.2; MADRS: -7.9).</text><annotation id="0"><infon key="type">DrugName</infon><location offset="80" length="9"/><text>asenapine</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="152" length="10"/><text>olanzapine</text></annotation></passage></document>
<document><id>21957976</id><passage><infon key="DDI">No</infon><offset>0</offset><text>Telmisartan-based plus Simvastatin treatment can significantly reduce SBP, reverse left ventricular hypertrophy, improve the left ventricular systolic function, but it has no effect on reversing the left ventricular diastolic function.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="0" length="11"/><text>telmisartan</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="23" length="11"/><text>simvastatin</text></annotation></passage></document>
<document><id>20585812</id><passage><infon key="DDI">No</infon><offset>0</offset><text>We report a case of safe perioperative management with general anesthesia, using total intravenous anesthesia, propofol, fentanyl and a non-depolarizing muscle relaxant but avoiding the use of any inhaled anesthetics or depolarizing muscle relaxants to prevent malignant hyperthermia and postoperative respiratory failure, during anesthetic management for cranioplasty for premature synostosis of the cranial sutures in a pediatric patient of CNMDU1.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="111" length="8"/><text>propofol</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="121" length="8"/><text>fentanyl</text></annotation></passage></document>
<document><id>19181308</id><passage><infon key="DDI">No</infon><offset>0</offset><text>In a preliminary study we found that the selective noradrenaline reuptake inhibitor, atomoxetine, a drug known to reduce impulsivity, prevented the reinstatement of cocaine-seeking.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="85" length="11"/><text>atomoxetine</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="165" length="7"/><text>cocaine</text></annotation></passage></document>
<document><id>20048199</id><passage><infon key="DDI">No</infon><offset>0</offset><text>Administration of enalaprilat had no additional effect, except for a modest reduction in cortical blood flow in the clipped kidney of 2K,1C rats when coadministered with candesartan (-10%).</text><annotation id="0"><infon key="type">DrugName</infon><location offset="18" length="11"/><text>enalaprilat</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="170" length="11"/><text>candesartan</text></annotation></passage></document>
<document><id>23029285</id><passage><infon key="DDI">No</infon><offset>0</offset><text>Our results show that patients treated with artesunate alone have significantly lower cure rates than those treated with praziquantel (OR = 0.27 (95% C.I. 0.13-0.53; p&lt;0.001)) and that the combined therapy of artesunate plus sulfadoxine-pyrimethamine is also significantly less effective than praziquantel treatment (OR = 0.14 (95% C.I. 0.02-0.92; p = 0.04)).</text><annotation id="0"><infon key="type">DrugName</infon><location offset="237" length="13"/><text>pyrimethamine</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="293" length="12"/><text>praziquantel</text></annotation></passage></document>
<document><id>20552222</id><passage><infon key="DDI">No</infon><offset>0</offset><text>The microvascular responses to endothelium-dependent vasodilators (e.g., acetylcholine), endothelium-independent vasodilators (e.g., sodium nitroprusside), and to local heating were studied (for the first time) in adolescents with essential hypertension, grouped according to their body mass index.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="73" length="13"/><text>acetylcholine</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="140" length="13"/><text>nitroprusside</text></annotation></passage></document>
<document><id>22157069</id><passage><infon key="DDI">No</infon><offset>0</offset><text>The patients had lower testosterone/estradiol (E(2)) ratio and inhibin B, and higher FSH.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="23" length="12"/><text>testosterone</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="36" length="9"/><text>estradiol</text></annotation></passage></document>
<document><id>22286020</id><passage><infon key="DDI">No</infon><offset>0</offset><text>CONCLUSION: Since acute DAM administration suppresses the stress response, DAM-assisted treatment may be an effective alternative to methadone maintenance in stress-sensitive heroin-dependent patients.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="133" length="9"/><text>methadone</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="175" length="6"/><text>heroin</text></annotation></passage></document>
<document><id>21983846</id><passage><infon key="DDI">No</infon><offset>0</offset><text>Hyperkalemia (>5.5 mmol/L) was observed in infants with an APN diagnosis, who exhibited a lower transtubular potassium concentration gradient (TTKG) and a higher fractional sodium excretion.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="109" length="9"/><text>potassium</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="173" length="6"/><text>sodium</text></annotation></passage></document>
<document><id>23099938</id><passage><infon key="DDI">No</infon><offset>0</offset><text>Regarding carbamazepine and caffeine, further investigations are needed to determine possible management and environmental conditions that could prevent accumulation.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="10" length="13"/><text>carbamazepine</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="28" length="8"/><text>caffeine</text></annotation></passage></document>
<document><id>19348734</id><passage><infon key="DDI">No</infon><offset>0</offset><text>The mechanisms by which minocycline interferes with the development of cocaine sensitization need to be characterized.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="24" length="11"/><text>minocycline</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="71" length="7"/><text>cocaine</text></annotation></passage></document>
<document><id>22813448</id><passage><infon key="DDI">No</infon><offset>0</offset><text>With a wholesale cost of $1850 per dose, the cost per patient with aflibercept treatment promises to be lower than with ranibizumab.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="67" length="11"/><text>aflibercept</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="120" length="11"/><text>ranibizumab</text></annotation></passage></document>
<document><id>20085586</id><passage><infon key="DDI">No</infon><offset>0</offset><text>Patients that were homozygous for the reference alleles SSTR4 rs2567608 (AA) and EPHA7 rs2278107 (TT) showed lower disease control rates in response to irinotecan and oxaliplatin regimens, respectively, than those with substitution alleles (P = 0.022 and 0.014, respectively).</text><annotation id="0"><infon key="type">DrugName</infon><location offset="152" length="10"/><text>irinotecan</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="167" length="11"/><text>oxaliplatin</text></annotation></passage></document>
<document><id>23136005</id><passage><infon key="DDI">No</infon><offset>0</offset><text>Moreover, basal rSNA was increased in offspring from diabetic dams, and baroreceptor control of rSNA was impaired, with blunted responses to infusion of nitroprusside and phenylephrine.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="153" length="13"/><text>nitroprusside</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="171" length="13"/><text>phenylephrine</text></annotation></passage></document>
<document><id>21671024</id><passage><infon key="DDI">No</infon><offset>0</offset><text>The concentrations of sodium, chloride, calcium, and potassium of fish fed the control diet were significantly lower than in fish fed nucleotide-supplemented diet.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="40" length="7"/><text>calcium</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="53" length="9"/><text>potassium</text></annotation></passage></document>
<document><id>21982171</id><passage><infon key="DDI">No</infon><offset>0</offset><text>Additionally, the use of dexamethasone to prevent nausea and vomiting triggered by intravenous or epidural morphine for pain control can also offer a good therapeutic effect.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="25" length="13"/><text>dexamethasone</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="107" length="8"/><text>morphine</text></annotation></passage></document>
<document><id>21037391</id><passage><infon key="DDI">No</infon><offset>0</offset><text>There is some evidence that sevelamer hydrochloride can attenuate cardiovascular calcification compared with calcium-based phosphate binders.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="28" length="9"/><text>sevelamer</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="109" length="7"/><text>calcium</text></annotation></passage></document>
<document><id>21146875</id><passage><infon key="DDI">No</infon><offset>0</offset><text>The results showed lower level of plasma 3,4-dihydroxyphenylacetic acid (DOPAC) in relapsed versus first-episode schizophrenic patients, higher norepinephrine (NE) turnover rate (TR) in undifferentiated in comparison to paranoid schizophrenic patients and relatively higher metabolic activity of dopamine (DA) to serotonin (5-HT) in first-episode versus relapsed schizophrenic patients.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="144" length="14"/><text>norepinephrine</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="296" length="8"/><text>dopamine</text></annotation></passage></document>
<document><id>23439586</id><passage><infon key="DDI">No</infon><offset>0</offset><text>Human data suggest that eplerenone and spironolactone lowers blood pressure by mechanisms independent of the distal tubule.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="24" length="10"/><text>eplerenone</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="39" length="14"/><text>spironolactone</text></annotation></passage></document>
<document><id>21383939</id><passage><infon key="DDI">No</infon><offset>0</offset><text>In recent years, the development of a sustained-release dexamethasone intravitreal implant (Ozurdex(®)) has enabled more controlled drug release at a stable rate over a long period of time, with a potentially lower rate of adverse events.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="56" length="13"/><text>dexamethasone</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="92" length="7"/><text>ozurdex</text></annotation></passage></document>
<document><id>21929838</id><passage><infon key="DDI">No</infon><offset>0</offset><text>The present study investigated the postprandial glucose, insulin and glucagon-like peptide 1 (GLP-1) responses to sucrose ingested with berries, in comparison with a similar sucrose load without berries.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="69" length="8"/><text>glucagon</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="174" length="7"/><text>sucrose</text></annotation></passage></document>
<document><id>23125251</id><passage><infon key="DDI">No</infon><offset>0</offset><text>Compared with 2D cultures, microtissues demonstrated identical responses to acetylcholine and KCl, but not histamine, forskolin, or cytochalasin D, suggesting that contractility is regulated by substrate geometry.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="76" length="13"/><text>acetylcholine</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="118" length="9"/><text>forskolin</text></annotation></passage></document>
<document><id>22895064</id><passage><infon key="DDI">No</infon><offset>0</offset><text>In conclusion, our findings suggest that aliskiren prevents and ameliorates insulin resistance, aortic endothelial dysfunction and oxidative vascular remodeling in fructose-fed hypertensive rats.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="41" length="9"/><text>aliskiren</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="164" length="8"/><text>fructose</text></annotation></passage></document>
<document><id>19690072</id><passage><infon key="DDI">No</infon><offset>0</offset><text>These results suggested that the intermittent hypoxia stimulated the secretion of testosterone at least in part via stimulatory actions on the activities of adenylyl cyclase, cAMP, L-type calcium channel, and steroidogenic enzymes.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="82" length="12"/><text>testosterone</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="188" length="7"/><text>calcium</text></annotation></passage></document>
<document><id>19427327</id><passage><infon key="DDI">No</infon><offset>0</offset><text>A novel polyhydroxylated C(29)-sterol, 25xi-methyl-22-homo-5alpha-cholest-7,22-diene-3beta,6beta,9alpha-triol, designated globosterol (1), together with one known tetrahydroxylated ergosterol (22E, 24R)-ergosta-7,22-diene-3beta,5alpha,6beta,9alpha-tetraol (2) has been isolated from the cultures of an endophytic fungus, Chaetomium globosum ZY-22 originated from the plant Ginkgo biloba.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="373" length="13"/><text>ginkgo biloba</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="181" length="10"/><text>ergosterol</text></annotation></passage></document>
<document><id>19587615</id><passage><infon key="DDI">No</infon><offset>0</offset><text>CONCLUSIONS: Sodium bicarbonate plus epinephrine shortens the onset and prolongs the duration of a chloroprocaine-bupivacaine sciatic block in Sprague-Dawley rats.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="99" length="14"/><text>chloroprocaine</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="114" length="11"/><text>bupivacaine</text></annotation></passage></document>
<document><id>21539885</id><passage><infon key="DDI">No</infon><offset>0</offset><text>Biochemical examination revealed that HMWPT significantly increased the decreased activities of superoxide dismutase (SOD), catalase (CAT), elevated the lowered total anti-oxidation capability (T-AOC), glutathione (GSH) and hydroxyproline (Hyp) contents (p&lt;0.01 or p&lt;0.05), and decreased the raised monoamine oxidase (MAO), total cholinesterase (TChE) activities and MDA level (p&lt;0.01) in serum, liver or brain of aging mice induced by d-gal in a dose-dependent fashion.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="202" length="11"/><text>glutathione</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="224" length="14"/><text>hydroxyproline</text></annotation></passage></document>
<document><id>19892760</id><passage><infon key="DDI">No</infon><offset>0</offset><text>As anticipated, RecA of L. monocytogenes plays a role in mutagenesis; DeltarecA cultures showed considerably lower rifampicin- and streptomycin-resistant fractions than the wild-type cultures.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="115" length="10"/><text>rifampicin</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="131" length="12"/><text>streptomycin</text></annotation></passage></document>
<document><id>21895761</id><passage><infon key="DDI">No</infon><offset>0</offset><text>Thus, the more rapid onset, higher potency and lower interindividual variability of antiplatelet effects of prasugrel as compared to clopidogrel in vivo are entirely because of its more efficient pharmacokinetics.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="108" length="9"/><text>prasugrel</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="133" length="11"/><text>clopidogrel</text></annotation></passage></document>
<document><id>22585829</id><passage><infon key="DDI">No</infon><offset>0</offset><text>Based on our previous findings that activation of ACTH signaling changes the ratio of nicotinamide adenine dinucleotide (NAD) phosphate to reduced NAD phosphate in adrenocortical cells, we hypothesized that pyridine nucleotide metabolism may regulate the activity of the mitochondrial NAD(+)-dependent sirtuin (SIRT) deacetylases.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="86" length="12"/><text>nicotinamide</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="99" length="7"/><text>adenine</text></annotation></passage></document>
<document><id>22548038</id><passage><infon key="DDI">No</infon><offset>0</offset><text>He was treated with erythromycin and methylprednisolone reduced gradually over 5 months, with a slow but complete response; the patient was without lesions after 2 years of follow-up.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="20" length="12"/><text>erythromycin</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="37" length="18"/><text>methylprednisolone</text></annotation></passage></document>
<document><id>21715107</id><passage><infon key="DDI">No</infon><offset>0</offset><text>CONCLUSION: Thus, the efficacy of memantine 30 or 60 mg/day as an adjunct to oral naltrexone for the treatment of opiate dependence was not supported.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="34" length="9"/><text>memantine</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="82" length="10"/><text>naltrexone</text></annotation></passage></document>
<document><id>21478293</id><passage><infon key="DDI">No</infon><offset>0</offset><text>Serotonin and norepinephrine concentrations were decreased in hypothalamus and cortex in co- and post-treated folic acid groups with hypothyroid rats, while the concentration of dopamine were significantly increased in the hypothalamus and hippocampus of the hypothyroid rats and co-treated folic acid group with hypothyroid rats.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="14" length="14"/><text>norepinephrine</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="178" length="8"/><text>dopamine</text></annotation></passage></document>
<document><id>23119054</id><passage><infon key="DDI">No</infon><offset>0</offset><text>Then, we injected the zinc chelator, clioquinol (CQ, 30 mg/kg), into the intraperitoneal space to reduce brain zinc availability.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="37" length="10"/><text>clioquinol</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="111" length="4"/><text>zinc</text></annotation></passage></document>
<document><id>23258767</id><passage><infon key="DDI">No</infon><offset>0</offset><text>Unpaid (family) carer costs were lower with mirtazapine than sertraline or placebo.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="44" length="11"/><text>mirtazapine</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="61" length="10"/><text>sertraline</text></annotation></passage></document>
<document><id>19824805</id><passage><infon key="DDI">No</infon><offset>0</offset><text>We suggest using a priming dose of propofol 1.5 mg.kg(-1) to suppress cough during the anesthesia induction with propofol and fentanyl in clinical practice.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="113" length="8"/><text>propofol</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="126" length="8"/><text>fentanyl</text></annotation></passage></document>
<document><id>23373409</id><passage><infon key="DDI">No</infon><offset>0</offset><text>Their antioxidant properties are linked to the ability to chelate transitional metal ions, mainly copper and iron and to increase antioxidant capacity by the stimulation of the activity of important antioxidant enzymes: superoxide dismutase, glutathione peroxidase and catalase.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="109" length="4"/><text>iron</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="242" length="11"/><text>glutathione</text></annotation></passage></document>
<document><id>22945941</id><passage><infon key="DDI">No</infon><offset>0</offset><text>Moreover, largely degraded phenylpropanoids, flavonoid compounds, and sucrose together with markedly produced glycerol, gluconic acid, and succinate, all being directly associated with B. cinerea growth, were only found in botrytized berries of botrytized bunches.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="70" length="7"/><text>sucrose</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="110" length="8"/><text>glycerol</text></annotation></passage></document>
<document><id>19389194</id><passage><infon key="DDI">No</infon><offset>0</offset><text>We hypothesized that chronic ethanol ingestion would increase the risk of infection even though GBS is less pathogenic but that dietary N-acetylcysteine (NAC), a glutathione precursor, would improve in vivo clearance of infectious particles and reduce systemic infection.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="138" length="14"/><text>acetylcysteine</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="162" length="11"/><text>glutathione</text></annotation></passage></document>
<document><id>20592607</id><passage><infon key="DDI">No</infon><offset>0</offset><text>Recently, two separate clinical trials have found that denosumab, a monoclonal antibody, and toremifene citrate, a selective estrogen receptor modulator, could be used to reduce the incidence of fracture in men on ADT.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="55" length="9"/><text>denosumab</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="93" length="10"/><text>toremifene</text></annotation></passage></document>
<document><id>21036344</id><passage><infon key="DDI">No</infon><offset>0</offset><text>Two laccase isoenzyme genes (lcc2 and lcc3) from the white-rot fungus Coriolopsis rigida were cloned, and together with the previously described lcc1, their transcript levels were analysed by Quantitative RT-PCR in order to study their expression patterns under a range of putative inducers (Cu(2+), Mn(2+), Fe(3+), 2,6-dimethoxy-1,4-benzoquinone, H(2)O(2,) caffeine, amphotericin B and syringic acid).</text><annotation id="0"><infon key="type">DrugName</infon><location offset="358" length="8"/><text>caffeine</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="368" length="12"/><text>amphotericin</text></annotation></passage></document>
<document><id>20201378</id><passage><infon key="DDI">No</infon><offset>0</offset><text>The authors have compared the informative value of the tests determining the activity of adenosine deaminase (ADA) and the levels of interferon-gamma (INF-gamma) and neopterin in the diagnosis of pleural effusions of tuberculous (n = 67) and nontuberculous (n = 30) origin.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="89" length="9"/><text>adenosine</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="166" length="9"/><text>neopterin</text></annotation></passage></document>
<document><id>22483275</id><passage><infon key="DDI">No</infon><offset>0</offset><text>It will be important to determine if these actions of choline on human cognition are mediated by epigenomic mechanisms or by its influence on acetylcholine or phospholipid synthesis.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="148" length="7"/><text>choline</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="142" length="13"/><text>acetylcholine</text></annotation></passage></document>
<document><id>23079899</id><passage><infon key="DDI">No</infon><offset>0</offset><text>OBJECTIVE: The objective of the study was to use acute phencyclidine (PCP) treatment to model the cognitive deficits of schizophrenia in mice, and to test the efficacy of the novel, dopamine D(3)-receptor-preferring drug cariprazine in ameliorating the severity of PCP-triggered cognitive deficits.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="55" length="13"/><text>phencyclidine</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="182" length="8"/><text>dopamine</text></annotation></passage></document>
<document><id>22648048</id><passage><infon key="DDI">No</infon><offset>0</offset><text>Free radicals generated during ACR administration reduced the activities of membrane adenosine triphosphatases and acetylcholine esterase.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="85" length="9"/><text>adenosine</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="115" length="13"/><text>acetylcholine</text></annotation></passage></document>
<document><id>21240520</id><passage><infon key="DDI">No</infon><offset>0</offset><text>After the experimental period, lenses were taken out and the activities of superoxide dismutase (SOD), catalase, Ca(2+) ATPase, levels of reduced glutathione (GSH), calcium, reactive oxygen species (ROS), thiobarbituric acid reactive substances (TBARS), and sulfhydryl content were studied.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="146" length="11"/><text>glutathione</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="165" length="7"/><text>calcium</text></annotation></passage></document>
<document><id>21351441</id><passage><infon key="DDI">No</infon><offset>0</offset><text>The lower limits of quantification were 15 pg mL(-1) and 8 pg mL(-1) for lopinavir and ritonavir, respectively.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="73" length="9"/><text>lopinavir</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="87" length="9"/><text>ritonavir</text></annotation></passage></document>
<document><id>22302271</id><passage><infon key="DDI">No</infon><offset>0</offset><text>Anti-inflammatory drugs, dexamethasone and Celebrex, could inhibit extracellular mucin production in PMP by targeting inflammatory cascades and, therefore, may decrease compressive symptoms, increase the disease-free interval, and reduce the extent or frequency of morbid cytoreductive surgeries.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="25" length="13"/><text>dexamethasone</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="43" length="8"/><text>celebrex</text></annotation></passage></document>
<document><id>22256849</id><passage><infon key="DDI">No</infon><offset>0</offset><text>For the first 2 or 3 days of hospitalization, percentage changes in potassium, lactate, and ionized calcium concentrations were significantly higher and percentage changes in pH and plasma glucose and bicarbonate concentrations were significantly lower in nonsurvivors.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="68" length="9"/><text>potassium</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="100" length="7"/><text>calcium</text></annotation></passage></document>
<document><id>22760692</id><passage><infon key="DDI">No</infon><offset>0</offset><text>Compared with simvastatin 20 mg/day, cholesterol goal attainment was significantly higher with any dose of atorvastatin and rosuvastatin, but were lower with any dose of pravastatin.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="124" length="12"/><text>rosuvastatin</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="170" length="11"/><text>pravastatin</text></annotation></passage></document>
<document><id>20349194</id><passage><infon key="DDI">No</infon><offset>0</offset><text>BAE-treated groups showed marked decreases in serum-glucose levels, triglyceride concentrations, aspartate aminotransferase (AST), creatinine phosphokinase (CPK) activities, and lipid peroxide products (malondialdehyde, MDA) as well as an increase in glutathione level in both serum and muscular tissue compared to albendazole-treated- and infected-untreated groups.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="251" length="11"/><text>glutathione</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="315" length="11"/><text>albendazole</text></annotation></passage></document>
<document><id>22740111</id><passage><infon key="DDI">No</infon><offset>0</offset><text>However, in the EUA group, uterine superoxide dismutase and glutathione peroxidase activities were lower than in other groups.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="27" length="7"/><text>uterine</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="60" length="11"/><text>glutathione</text></annotation></passage></document>
<document><id>21077496</id><passage><infon key="DDI">No</infon><offset>0</offset><text>RESULTS: Significantly lower implantation rates were seen with ganirelix compared to leuprolide acetate or cetrorelix.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="85" length="10"/><text>leuprolide</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="107" length="10"/><text>cetrorelix</text></annotation></passage></document>
<document><id>20613471</id><passage><infon key="DDI">No</infon><offset>0</offset><text>Group 0 received radiofrequency denervation based solely on clinical findings; group 1 underwent denervation contingent on a positive response to a single diagnostic block; and group 2 proceeded to denervation only if they obtained a positive response to comparative blocks done with lidocaine and bupivacaine.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="284" length="9"/><text>lidocaine</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="298" length="11"/><text>bupivacaine</text></annotation></passage></document>
<document><id>19142756</id><passage><infon key="DDI">No</infon><offset>0</offset><text>On the basis of the circadian mesors of the testosterone rhythms, three distinct categories could be identified: category A (i.e., normal breeding concentrations of plasma testosterone), which includes control, sham-operated, and vehicle-treated groups; category A(+) (i.e., concentrations of plasma testosterone higher than that found in normal breeding quail), which includes 12 h, 12 h+vehicle-treated, and Px quails; and category A(-) (concentrations of plasma testosterone lower than that found in normal breeding quail), which includes 8 h, melatonin-, and 12 h+melatonin-treated groups.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="465" length="12"/><text>testosterone</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="568" length="9"/><text>melatonin</text></annotation></passage></document>
<document><id>22870104</id><passage><infon key="DDI">No</infon><offset>0</offset><text>Gefitinib (ZD1839, Iressa(®)) is an orally active agent that inhibits the tyrosine kinase activity of epidermal growth factor receptor (EGFR).</text><annotation id="0"><infon key="type">DrugName</infon><location offset="0" length="9"/><text>gefitinib</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="19" length="6"/><text>iressa</text></annotation></passage></document>
<document><id>19708827</id><passage><infon key="DDI">No</infon><offset>0</offset><text>The costs of balsalazide capsules seem to be lower for the health system, both considering total direct healthcare costs and better outcomes, compared with patients treated with oral mesalazine.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="13" length="11"/><text>balsalazide</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="183" length="10"/><text>mesalazine</text></annotation></passage></document>
<document><id>19780564</id><passage><infon key="DDI">No</infon><offset>0</offset><text>We report a hydrogen-bond functionalized N4Py ligand platform (N,N-bis(2-R-6-pyridylmethyl)-N-bis(2-pyridyl)methylamine; R = neopentyl-NH, N4Py(2NpNH), 9; R = phenyl-NH, N4Py(2PhNH), 10) and the ability of its iron(II)-triflate [N4Py(2R)Fe(II)(OTf)][OTf] complexes (R = NpNH, 11; R = PhNH, 12) to activate and reduce dioxygen in a synthetic cycle by coupled proton and electron transfer.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="108" length="11"/><text>methylamine</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="210" length="4"/><text>iron</text></annotation></passage></document>
<document><id>22371793</id><passage><infon key="DDI">No</infon><offset>0</offset><text>MATERIAL AND METHODS: We determined the activities of superoxide dismutase (SOD-1) and glutathione peroxidase (GSH-Px) and the concentration of malondialdehyde (MDA) in erythrocytes of 27 elderly (mean age 72.5 ±6.1 year) hypertensive patients treated with indapamide at baseline and after 12 weeks of CoQ supplementation (60 mg twice a day) in comparison with 30 healthy elderly volunteers (mean age 76.8 ±8.5 year).</text><annotation id="0"><infon key="type">DrugName</infon><location offset="87" length="11"/><text>glutathione</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="257" length="10"/><text>indapamide</text></annotation></passage></document>
<document><id>19467177</id><passage><infon key="DDI">No</infon><offset>0</offset><text>The mean number of asthma exacerbations requiring treatment with systemic steroid bursts in cat allergen-sensitive patients was lower in those receiving omalizumab versus placebo (0.6 versus 1.3, respectively; relative risk = 0.50, p &lt; 0.001).</text><annotation id="0"><infon key="type">DrugName</infon><location offset="96" length="8"/><text>allergen</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="153" length="10"/><text>omalizumab</text></annotation></passage></document>
<document><id>23095147</id><passage><infon key="DDI">No</infon><offset>0</offset><text>The limitation of slow bulk phase diffusion on the evaporation rate is investigated for gel and glass states formed during the evaporation of magnesium sulfate and sucrose droplets, respectively.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="142" length="9"/><text>magnesium</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="164" length="7"/><text>sucrose</text></annotation></passage></document>
<document><id>22652745</id><passage><infon key="DDI">No</infon><offset>0</offset><text>Protocols to prevent peritonitis related to exit site infection include exit site mupirocin or exit site gentamicin as part of routine care.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="82" length="9"/><text>mupirocin</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="105" length="10"/><text>gentamicin</text></annotation></passage></document>
<document><id>23545664</id><passage><infon key="DDI">No</infon><offset>0</offset><text>CONCLUSION: The ability of irbesartan to reduce BP is comparable to that of olmesartan, and irbesartan exhibits a lower variance of systolic BP after treatment.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="76" length="10"/><text>olmesartan</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="92" length="10"/><text>irbesartan</text></annotation></passage></document>
<document><id>22452737</id><passage><infon key="DDI">No</infon><offset>0</offset><text>BACKGROUND AND AIMS: Few studies have adequately examined the efficacy of lamivudine plus adefovir (LAM+ADV) combination therapy vs. entecavir (ETV) monotherapy in HBeAg-positive hepatitis B patients who fail to respond to sequential treatment with LAM and ADV.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="74" length="10"/><text>lamivudine</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="133" length="9"/><text>entecavir</text></annotation></passage></document>
<document><id>21372503</id><passage><infon key="DDI">No</infon><offset>0</offset><text>Although TOF monitoring was not utilized in this case and assessing residual muscular block was difficult, spontaneous respirations continued and breathing had to be controlled with sevoflurane and remifentanil.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="182" length="11"/><text>sevoflurane</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="198" length="12"/><text>remifentanil</text></annotation></passage></document>
<document><id>21159940</id><passage><infon key="DDI">No</infon><offset>0</offset><text>In the absence of clinical breakpoints (CBPs) for posaconazole, these WT distributions and ECVs will be useful in surveillance for emergence of reduced susceptibility to posaconazole among Candida spp. Whereas a CBP for susceptibility of = 1 µg/ml has been established for voriconazole and all species of Candida, it is notable that ECVs for this agent range from 10- to >100-fold lower than the CBP, depending on the species of Candida.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="170" length="12"/><text>posaconazole</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="273" length="12"/><text>voriconazole</text></annotation></passage></document>
<document><id>23141888</id><passage><infon key="DDI">No</infon><offset>0</offset><text>Encouraging data from recent experimental and phase-II studies tend to confirm that the FXR agonist obeticholic acid and the PPARa agonists bezafibrate and fenofibrate may be used as add-on therapies in PBC patients with inadequate responses to UDCA or even as alternative first-line agents.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="140" length="11"/><text>bezafibrate</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="156" length="11"/><text>fenofibrate</text></annotation></passage></document>
<document><id>22068290</id><passage><infon key="DDI">No</infon><offset>0</offset><text>The dissolution time, t(25), of theophylline matrices was significantly lower (p &lt; 0.001) than those of carvedilol matrix tablets.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="32" length="12"/><text>theophylline</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="104" length="10"/><text>carvedilol</text></annotation></passage></document>
<document><id>21206443</id><passage><infon key="DDI">No</infon><offset>0</offset><text>CONCLUSION: Fluoxetine and Citalopram can effectively reduce the severity of depression in diabetic patients without an adverse effect on glycemic control.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="12" length="10"/><text>fluoxetine</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="127" length="10"/><text>citalopram</text></annotation></passage></document>
<document><id>21242361</id><passage><infon key="DDI">No</infon><offset>0</offset><text>Increased doses of clopidogrel or aspirin did not prevent cardiovascular events.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="19" length="11"/><text>clopidogrel</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="34" length="7"/><text>aspirin</text></annotation></passage></document>
<document><id>21175312</id><passage><infon key="DDI">No</infon><offset>0</offset><text>CONCLUSIONS: Among patients undergoing hip replacement, thromboprophylaxis with apixaban, as compared with enoxaparin, was associated with lower rates of venous thromboembolism, without increased bleeding.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="80" length="8"/><text>apixaban</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="107" length="10"/><text>enoxaparin</text></annotation></passage></document>
<document><id>23072976</id><passage><infon key="DDI">No</infon><offset>0</offset><text>Three contemporary AIM scales have then been validated pharmacologically using agents that are known to reduce LID clinically and in primates (amantadine) or to interfere with the activity of L-DOPA (the D(1) and D(2) dopamine receptor antagonists, SCH-23390 and raclopride) respectively.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="143" length="10"/><text>amantadine</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="218" length="8"/><text>dopamine</text></annotation></passage></document>
<document><id>19348599</id><passage><infon key="DDI">No</infon><offset>0</offset><text>CONCLUSIONS: A small percentage of patients face retinal functional alterations and ocular lesions and that is possible thanks to the use of lower dosages of hydroxychloroquine (Hy) and chloroquine (CQ), but the problem still remains because of the cumulative dose of the drugs in therapy that many of these patients go through.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="158" length="18"/><text>hydroxychloroquine</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="186" length="11"/><text>chloroquine</text></annotation></passage></document>
<document><id>19079637</id><passage><infon key="DDI">No</infon><offset>0</offset><text>In the absence of its physiological acceptor, DTA catalyzes the slow hydrolysis of NAD(+) to ADP-ribose and nicotinamide, a reaction that can be exploited to measure kinetic isotope effects (KIEs) of isotopically labeled NAD(+)s.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="97" length="6"/><text>ribose</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="108" length="12"/><text>nicotinamide</text></annotation></passage></document>
<document><id>22589472</id><passage><infon key="DDI">No</infon><offset>0</offset><text>This is the first randomized study showing that iron chelation with deferasirox significantly reduces iron overload in NTDT patients with a frequency of overall adverse events similar to placebo.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="68" length="11"/><text>deferasirox</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="102" length="4"/><text>iron</text></annotation></passage></document>
<document><id>19210667</id><passage><infon key="DDI">No</infon><offset>0</offset><text>Serum insulin-like growth factor-I and leptin concentrations enhanced (p &lt; 0.05) with the increased feed intake, but progesterone concentrations were lower (p &lt; 0.05) in H than M and L groups and no difference (p > 0.05) between M and L on days 25 and 35 of pregnancy.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="39" length="6"/><text>leptin</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="117" length="12"/><text>progesterone</text></annotation></passage></document>
<document><id>19586414</id><passage><infon key="DDI">No</infon><offset>0</offset><text>RESULTS: Exposure to nonoxynol-9 (N-9) or cellulose sulfate (CS), but not 9-[2-(phosphonomethoxy)propyl]adenine (also referred to as tenofovir) or PRO2000, resulted in a rapid and sustained reduction in TER and a marked increase in HIV infection of T cells cultured in the lower chamber.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="104" length="7"/><text>adenine</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="133" length="9"/><text>tenofovir</text></annotation></passage></document>
<document><id>21060782</id><passage><infon key="DDI">No</infon><offset>0</offset><text>The SOS response induced by berberine was much lower compared to that induced by mitomycin C in an SOS response reporter strain.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="28" length="9"/><text>berberine</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="81" length="9"/><text>mitomycin</text></annotation></passage></document>
<document><id>21523784</id><passage><infon key="DDI">No</infon><offset>0</offset><text>The release of diclofenac (20%, w/w) was studied from lipidic solid dispersions using three different chemical forms (acid, sodium salt, and pyrrolidine ethanol salt) and two different lipid carriers (Compritol 888 ATO or Carnauba wax) either free or together with varying amounts (10%-30%, w/w) of stearic acid.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="15" length="10"/><text>diclofenac</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="153" length="7"/><text>ethanol</text></annotation></passage></document>
<document><id>21220527</id><passage><infon key="DDI">No</infon><offset>0</offset><text>In acute lethal infections induced with a penicillin-intermediate Streptococcus pneumoniae strain in immunocompetent mice, or with MRSA, GISA, and VRE strains in neutropenic mice, the 50% effective dose (ED(50)) values of NAI-107 were comparable or lower than those of reference compounds, irrespective of the strain and immune status (0.51 to 14.2 mg/kg of body weight for intravenous [i.v.] NAI-107, 5.1 to 22.4 for oral linezolid, and 22.4 for subcutaneous [s.c.] vancomycin).</text><annotation id="0"><infon key="type">DrugName</infon><location offset="423" length="9"/><text>linezolid</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="467" length="10"/><text>vancomycin</text></annotation></passage></document>
<document><id>22093096</id><passage><infon key="DDI">No</infon><offset>0</offset><text>Comparison of the efficacy of intralesional triamcinolone acetonide and 5-fluorouracil tattooing for the treatment of keloids.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="44" length="13"/><text>triamcinolone</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="74" length="12"/><text>fluorouracil</text></annotation></passage></document>
<document><id>21545622</id><passage><infon key="DDI">No</infon><offset>0</offset><text>WHAT IS NEW AND CONCLUSION:   The two cases reported here and the brief literature review emphasize the potential interaction between two drugs frequently coadministered, simvastatin and diltiazem and we suggest that diltiazem should not be used with higher doses of those statins metabolized by CYP3A such as simvastatin or atorvastatin and even with lower doses caution should be exercised in patients who may have cause for impaired metabolism.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="310" length="11"/><text>simvastatin</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="325" length="12"/><text>atorvastatin</text></annotation></passage></document>
<document><id>23075937</id><passage><infon key="DDI">No</infon><offset>0</offset><text>Importantly, soy does not appear to interfere with tamoxifen or anastrozole therapy.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="51" length="9"/><text>tamoxifen</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="64" length="11"/><text>anastrozole</text></annotation></passage></document>
<document><id>22719882</id><passage><infon key="DDI">No</infon><offset>0</offset><text>CONCLUSIONS/SIGNIFICANCE: Tenofovir/emtricitabine treatment, lower bone formation and lower fat mass predicted subsequent bone loss.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="26" length="9"/><text>tenofovir</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="36" length="13"/><text>emtricitabine</text></annotation></passage></document>
<document><id>22445539</id><passage><infon key="DDI">No</infon><offset>0</offset><text>Pharmacodynamic responses to combined treatment regimens with the calcium sensing receptor antagonist JTT-305/MK-5442 and alendronate in osteopenic ovariectomized rats.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="66" length="7"/><text>calcium</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="122" length="11"/><text>alendronate</text></annotation></passage></document>
<document><id>20690006</id><passage><infon key="DDI">No</infon><offset>0</offset><text>The aim of the study was to evaluate the efficacy of nebivolol alone and in association with hydrochlorothiazide (HCT) in reducing BP in hypertensive patients with new-onset, mild-to-moderate hypertension, and to assess the effect of combination therapy on glucose and lipid metabolism.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="53" length="9"/><text>nebivolol</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="93" length="19"/><text>hydrochlorothiazide</text></annotation></passage></document>
<document><id>20500734</id><passage><infon key="DDI">No</infon><offset>0</offset><text>AIM: To assess the efficacy of cisplatin in lipiodol emulsion combined with 5-fluorouracil (5-FU) for patients with HCC and portal vein tumour thrombosis.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="31" length="9"/><text>cisplatin</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="78" length="12"/><text>fluorouracil</text></annotation></passage></document>
<document><id>21142275</id><passage><infon key="DDI">No</infon><offset>0</offset><text>For example, the incremental cost-effectiveness ratio decreases by 46%, from £61, 900 to £33, 500 per QALY, for cinacalcet versus best supportive care for end-stage renal disease, and by 45%, from £31,100 to £17,000 per QALY, for imatinib versus interferon-a for chronic myeloid leukaemia.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="112" length="10"/><text>cinacalcet</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="230" length="8"/><text>imatinib</text></annotation></passage></document>
<document><id>22915969</id><passage><infon key="DDI">No</infon><offset>0</offset><text>CONCLUSION: Combination therapy with dutasteride and tamsulosin is highly efficacious as medical therapy for benign prostatic hyperplasia in patients with moderate-to-severe lower urinary tract symptoms.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="37" length="11"/><text>dutasteride</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="53" length="10"/><text>tamsulosin</text></annotation></passage></document>
<document><id>20591397</id><passage><infon key="DDI">No</infon><offset>0</offset><text>CONCLUSIONS: Topical administration of both bevacizumab and sunitinib inhibits corneal neovascularization in rabbits.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="44" length="11"/><text>bevacizumab</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="60" length="9"/><text>sunitinib</text></annotation></passage></document>
<document><id>20301639</id><passage><infon key="DDI">No</infon><offset>0</offset><text>Medications used with some success in pain management include mexilitene, gabapentin, nonsteroidal anti-inflammatory drugs (NSAIDS), low-dose thyroid replacement, low-dose steroids (e.g., 5 mg prednisone on alternate days), and tricyclic antidepressants.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="74" length="10"/><text>gabapentin</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="193" length="10"/><text>prednisone</text></annotation></passage></document>
<document><id>20688958</id><passage><infon key="DDI">No</infon><offset>0</offset><text>Silencing of MTF-1 reduces FPN1 transcription in response to zinc but not in response to iron.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="61" length="4"/><text>zinc</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="89" length="4"/><text>iron</text></annotation></passage></document>
<document><id>21741474</id><passage><infon key="DDI">No</infon><offset>0</offset><text>To enhance the efficacy of fenretinide (4HPR)-induced reactive oxygen species (ROS) in neuroblastoma, 4HPR was combined with buthionine sulfoximine (BSO), an inhibitor of glutathione (GSH) synthesis, in neuroblastoma cell lines and spheroids, the latter being a three-dimensional tumor model.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="27" length="11"/><text>fenretinide</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="171" length="11"/><text>glutathione</text></annotation></passage></document>
<document><id>23296254</id><passage><infon key="DDI">No</infon><offset>0</offset><text>CORM-3, but not iCORM, inhibited the endothelium-dependent relaxation to acetylcholine without affecting the response to sodium nitroprusside.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="73" length="13"/><text>acetylcholine</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="128" length="13"/><text>nitroprusside</text></annotation></passage></document>
<document><id>22691216</id><passage><infon key="DDI">No</infon><offset>0</offset><text>An important downstream target of TGF-ß is the Abelson (c-Abl) tyrosine kinase, and its inhibition by imatinib mesylate (Gleevec) attenuates fibrosis in mice.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="102" length="8"/><text>imatinib</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="121" length="7"/><text>gleevec</text></annotation></passage></document>
<document><id>21196696</id><passage><infon key="DDI">No</infon><offset>0</offset><text>BACKGROUND: Tamoxifen (TAM) and toremifene (TOR) prevent estrogen from stimulating breast cancer growth and also have agonistic effects in a number of physiological systems.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="12" length="9"/><text>tamoxifen</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="32" length="10"/><text>toremifene</text></annotation></passage></document>
<document><id>22486281</id><passage><infon key="DDI">No</infon><offset>0</offset><text>Androgen-producing enzymes, such as 5a-reductase (5aR), which converts testosterone locally to the potent androgen dihydrotestosterone, have recently gained attention in studies of the intratumoural actions of androgens.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="122" length="12"/><text>testosterone</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="115" length="19"/><text>dihydrotestosterone</text></annotation></passage></document>
<document><id>23557242</id><passage><infon key="DDI">No</infon><offset>0</offset><text>CONCLUSION: This study suggests that combined use of iloprost and montelukast may reduce ischemic damage in transient spinal cord ischemia and may provide better neurological outcome.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="53" length="8"/><text>iloprost</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="66" length="11"/><text>montelukast</text></annotation></passage></document>
<document><id>21849609</id><passage><infon key="DDI">No</infon><offset>0</offset><text>The iron chelator deferoxamine (500 µM) did not prevent H(2)O(2)-mediated neuronal augmentation but prevented the initial depression.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="4" length="4"/><text>iron</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="18" length="12"/><text>deferoxamine</text></annotation></passage></document>
<document><id>20471036</id><passage><infon key="DDI">No</infon><offset>0</offset><text>Arginine vasopressin (AVP) and norepinephrine (NE) were used to treat vasodilatory or septic shock, and were used to reduce the fluid requirement for uncontrolled hemorrhagic shock.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="9" length="11"/><text>vasopressin</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="31" length="14"/><text>norepinephrine</text></annotation></passage></document>
<document><id>22252673</id><passage><infon key="DDI">No</infon><offset>0</offset><text>Enalaprilat or chymostatin partly improved the reduced adhesive capacity of podocytes compared to cells exposed to mesangial medium (P &lt;0.05), but it was still lower than for podocytes exposed to mesangial medium containing aIgA1 from healthy controls (P &lt;0.05).</text><annotation id="0"><infon key="type">DrugName</infon><location offset="0" length="11"/><text>enalaprilat</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="15" length="11"/><text>chymostatin</text></annotation></passage></document>
<document><id>21913565</id><passage><infon key="DDI">No</infon><offset>0</offset><text>Results showed that the use of Carboprost tromethamole (Prostin 15M) in treatment of hypotony leads to fast and extended contraction of the uterus as well as significantly decreases blood loss and the necessity of haemotrasfusion.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="31" length="10"/><text>carboprost</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="56" length="7"/><text>prostin</text></annotation></passage></document>
<document><id>20564643</id><passage><infon key="DDI">No</infon><offset>0</offset><text>Adult patients received a median of 10 cycles of treatment, and a significantly lower total cumulative dose of ifosfamide and cyclophosphamide (P &lt; .0001).</text><annotation id="0"><infon key="type">DrugName</infon><location offset="111" length="10"/><text>ifosfamide</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="126" length="16"/><text>cyclophosphamide</text></annotation></passage></document>
<document><id>21544014</id><passage><infon key="DDI">No</infon><offset>0</offset><text>Significantly lower trough concentrations were noted in patients with SRDs receiving atazanavir (0.290 vs 0.976 µg/mL) or lopinavir (3.75 vs 5.30 µg/mL).</text><annotation id="0"><infon key="type">DrugName</infon><location offset="85" length="10"/><text>atazanavir</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="122" length="9"/><text>lopinavir</text></annotation></passage></document>
<document><id>21280989</id><passage><infon key="DDI">No</infon><offset>0</offset><text>Use of prostin/oxytocin was significantly lower in women who consumed dates (28%), compared with the non-date fruit consumers (47%) (p?=?0.036).</text><annotation id="0"><infon key="type">DrugName</infon><location offset="7" length="7"/><text>prostin</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="15" length="8"/><text>oxytocin</text></annotation></passage></document>
<document><id>21444354</id><passage><infon key="DDI">No</infon><offset>0</offset><text>The activities of catalase (CAT), superoxide dismutase (SOD), glutathione peroxidase (GSH-Px), xanthine oxidase (XO), and malondialdehyde (MDA) levels were determined in cerebellum specimens by using spectrophotometric methods.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="62" length="11"/><text>glutathione</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="95" length="8"/><text>xanthine</text></annotation></passage></document>
<document><id>23285253</id><passage><infon key="DDI">No</infon><offset>0</offset><text>METHODS: 35 HIV-1 infected patients being treated with first line antiretroviral therapy (ART, mean duration at inclusion: 2.7±1.3 years) containing boosted protease inhibitors (PI/r) (comprising lopinavir/ritonavir in 65% of patients) were recruited together with 49 seronegative age- and sex-matched control subjects (http://clinicaltrials.gov/, NCT01038999).</text><annotation id="0"><infon key="type">DrugName</infon><location offset="196" length="9"/><text>lopinavir</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="206" length="9"/><text>ritonavir</text></annotation></passage></document>
<document><id>19006566</id><passage><infon key="DDI">No</infon><offset>0</offset><text>VPA, but neither fludarabine nor cladribine, enhanced the production of reactive oxygen species (ROS) and inhibition of ROS with N-acetylcysteine decreases apoptosis of CLL cells.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="33" length="10"/><text>cladribine</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="131" length="16"/><text>n-acetylcysteine</text></annotation></passage></document>
<document><id>22028577</id><passage><infon key="DDI">No</infon><offset>0</offset><text>Treatment of verrucous carcinoma of the lower lip with topical imiquimod (aldara®) and debulking therapy.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="63" length="9"/><text>imiquimod</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="74" length="6"/><text>aldara</text></annotation></passage></document>
<document><id>19136637</id><passage><infon key="DDI">No</infon><offset>0</offset><text>Taken together, our findings demonstrated that ATPM, a novel mixed kappa-agonist and mu-agonist/-antagonist, could inhibit morphine-induced antinociceptive tolerance, with less potential to develop tolerance and reduce heroin self-administration with less sedative effect.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="123" length="8"/><text>morphine</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="219" length="6"/><text>heroin</text></annotation></passage></document>
<document><id>20134114</id><passage><infon key="DDI">No</infon><offset>0</offset><text>The forefront for novel therapeutic agents based on the pathophysiology of lower urinary tract dysfunction: ameliorative effect of solifenacin succinate (Vesicare), a bladder-selective antimuscarinic agent, on overactive bladder symptoms, especially urgency episodes.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="131" length="21"/><text>solifenacin succinate</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="154" length="8"/><text>vesicare</text></annotation></passage></document>
<document><id>20844783</id><passage><infon key="DDI">No</infon><offset>0</offset><text>The increased magnitude of the zeta potential and the pH(pzc) shift to lower pH suggest a surface reconstruction and the appearance of more acidic aluminium sites.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="57" length="3"/><text>pzc</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="147" length="9"/><text>aluminium</text></annotation></passage></document>
<document><id>21574547</id><passage><infon key="DDI">No</infon><offset>0</offset><text>The addition of ß-CD to the phloroglucinol dyes 1a,b resulted in a significant bathochromic shift in absorption, together with a ca. 1.5-2.5-fold enhancement in fluorescence intensity, whereas for the aniline-based dyes 2a,b, a hypsochromic shift in the absorption and a ca. 5-12-fold fluorescence enhancement were observed in a 10% (v/v) ethanol/water mixture.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="201" length="7"/><text>aniline</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="339" length="7"/><text>ethanol</text></annotation></passage></document>
<document><id>20620973</id><passage><infon key="DDI">No</infon><offset>0</offset><text>Additional monoclonal antibodies targeting CD20, CD23, CD37, CD38 or CD40, as well as drugs designed to interfere with proteins regulating the cell cycle, apoptotic machinery or leukaemic microenvironment (e.g., flavopiridol, oblimersen, ABT-263 or lenalidomide) are investigated in clinical trials.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="212" length="12"/><text>flavopiridol</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="249" length="12"/><text>lenalidomide</text></annotation></passage></document>
<document><id>20804674</id><passage><infon key="DDI">No</infon><offset>0</offset><text>CONCLUSIONS: Conscious sedation with clinically judged midazolam and alfentanil reduces discomforts, improves satisfaction, and carries slight, but manageable, hypoxemia risks in patients undergoing FB.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="55" length="9"/><text>midazolam</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="69" length="10"/><text>alfentanil</text></annotation></passage></document>
<document><id>22627608</id><passage><infon key="DDI">No</infon><offset>0</offset><text>The MONET study, comparing darunavir/ritonavir-based triple therapy and monotherapy, has found higher risk of failure in patients with positive HCV serology, but the effects of HCV co-infection on the efficacy of antiretroviral treatment have not been clearly established.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="27" length="9"/><text>darunavir</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="37" length="9"/><text>ritonavir</text></annotation></passage></document>
<document><id>22336394</id><passage><infon key="DDI">No</infon><offset>0</offset><text>METHODS: We report on a case of NSNEC treated with sequential chemo-radiation consisting of 6 cycles of cisplatin and etoposide followed by loco-regional radiation to the head and neck and simultaneous prophylactic cranial irradiation to prevent from intracranial spread, delivered with helical tomotherapy with the 'hippocampal avoidance' technique in order to reduce neuro-cognitive late effects.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="104" length="9"/><text>cisplatin</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="118" length="9"/><text>etoposide</text></annotation></passage></document>
<document><id>19410450</id><passage><infon key="DDI">No</infon><offset>0</offset><text>The specific activity of the P. rubrum immobilized pellets in calcium alginate at 30 degrees C ranged from 1.6 to 4.0 g isomaltulose g(-1) pellet h(-1), respectively with 70% and 65% sucrose solution, while in lower sucrose concentration had higher specific activities presumably due to substrate inhibition of the isomaltulose synthase in higher sucrose concentrations.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="62" length="7"/><text>calcium</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="347" length="7"/><text>sucrose</text></annotation></passage></document>
<document><id>22228936</id><passage><infon key="DDI">No</infon><offset>0</offset><text>We have selected a few photoprotective phytoconstituents, such as curcumin, resveratrol, tea polyphenols, silymarin, quercetin and ascorbic acid, and have discussed the considerations to be undertaken for the development of herbal cosmetic formulations that could reduce the occurrence of skin cancer and delay the process of photoaging.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="76" length="11"/><text>resveratrol</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="117" length="9"/><text>quercetin</text></annotation></passage></document>
<document><id>19826072</id><passage><infon key="DDI">No</infon><offset>0</offset><text>d-Asp also increases the ovarian and plasmatic levels of 17ß-estradiol and decreases those of testosterone.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="61" length="9"/><text>estradiol</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="94" length="12"/><text>testosterone</text></annotation></passage></document>
<document><id>23534492</id><passage><infon key="DDI">No</infon><offset>0</offset><text>Topical application of enoxaparin (ENX; low molecular weight heparin) prevents the occurrence of thrombosis at traumatic anastomosis site.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="23" length="10"/><text>enoxaparin</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="61" length="7"/><text>heparin</text></annotation></passage></document>
<document><id>22575324</id><passage><infon key="DDI">No</infon><offset>0</offset><text>Dabigatran 150 mg BID was superior to rivaroxaban for some efficacy endpoints, whereas major bleeding was significantly lower with dabigatran 110 mg BID or apixaban.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="38" length="11"/><text>rivaroxaban</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="156" length="8"/><text>apixaban</text></annotation></passage></document>
<document><id>21747891</id><passage><infon key="DDI">No</infon><offset>0</offset><text>In a previous paper we reported that electroacupuncture (EA) could suppress opioid withdrawal syndrome and increase the appetite, sleep, and body weight in heroin addicts or morphine dependent animals.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="156" length="6"/><text>heroin</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="174" length="8"/><text>morphine</text></annotation></passage></document>
<document><id>21336129</id><passage><infon key="DDI">No</infon><offset>0</offset><text>Finally, the presence of the functional F1Fo adenosine-5&amp;apos;-triphosphate synthase complex (0.51 vs. 1.00 ng oligo/mL/10(6) cells, p = .02), but not the adenine nucleotide translocator, was significantly lower in patients with septic shock compared with control cells.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="45" length="9"/><text>adenosine</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="155" length="7"/><text>adenine</text></annotation></passage></document>
<document><id>19884277</id><passage><infon key="DDI">No</infon><offset>0</offset><text>OBJECTIVE: The enzymatic activities of tissue-nonspecific alkaline phosphatase (TNAP) including capacity to inhibit calcium pyrophosphate dihydrate (CPPD) crystal dissolution are known to be inhibited by endogenous amino acids, notably cysteine.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="58" length="20"/><text>alkaline phosphatase</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="116" length="31"/><text>calcium pyrophosphate dihydrate</text></annotation></passage></document>
<document><id>20304778</id><passage><infon key="DDI">No</infon><offset>0</offset><text>The aim of this study is to prospectively evaluate the efficacy of combination chemotherapy with biweekly cetuximab and irinotecan in patients with pre-treated metastatic colorectal cancer harboring wild-type KRAS.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="106" length="9"/><text>cetuximab</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="120" length="10"/><text>irinotecan</text></annotation></passage></document>
<document><id>21334502</id><passage><infon key="DDI">No</infon><offset>0</offset><text>CONCLUSIONS: Intravenous lidocaine before anesthetic induction was capable of attenuating the hemodynamic response associated to OI maneuvers, but it did not reduce the latency of the neuromuscular blockade produced by two different doses of rocuronium.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="25" length="9"/><text>lidocaine</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="242" length="10"/><text>rocuronium</text></annotation></passage></document>
<document><id>21414882</id><passage><infon key="DDI">No</infon><offset>0</offset><text>Re: Ketoconazole and prednisone to prevent recurrent ischemic priapism.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="4" length="12"/><text>ketoconazole</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="21" length="10"/><text>prednisone</text></annotation></passage></document>
<document><id>20467834</id><passage><infon key="DDI">No</infon><offset>0</offset><text>In conclusion, the potency for block of hERG currents is about 100-fold lower for heroin when compared to methadone.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="82" length="6"/><text>heroin</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="106" length="9"/><text>methadone</text></annotation></passage></document>
<document><id>23190065</id><passage><infon key="DDI">No</infon><offset>0</offset><text>Despite clinical benefits of aspirin and clopidogrel therapy, a number of limitations curtail their efficacy: slow onset of action, variability in platelet inhibitory response and potential drug-drug interactions.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="29" length="7"/><text>aspirin</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="41" length="11"/><text>clopidogrel</text></annotation></passage></document>
<document><id>22787043</id><passage><infon key="DDI">No</infon><offset>0</offset><text>While these findings suggested a role for decreased 5-HT release in the mechanisms of STN DBS, further microdialysis experiments showed that when the 5-HT lowering effects of STN DBS were prevented by pretreatment with fluoxetine or fenfluramine, the ability of DBS to suppress VCMs remained unaltered.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="219" length="10"/><text>fluoxetine</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="233" length="12"/><text>fenfluramine</text></annotation></passage></document>
<document><id>22948132</id><passage><infon key="DDI">No</infon><offset>0</offset><text>CONCLUSION: Prophylactic treatment with the dopamine agonist, cabergoline, at lower doses (0.25mg) reduces the incidence of OHSS in women at high risk undergoing IVF/ICSI treatment.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="44" length="8"/><text>dopamine</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="62" length="11"/><text>cabergoline</text></annotation></passage></document>
<document><id>21116174</id><passage><infon key="DDI">No</infon><offset>0</offset><text>High doses of galantamine, physostigmine or tacrine produced small but significant decreases in operant response rate, suggesting a possible underestimation of the degree of generalization.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="27" length="13"/><text>physostigmine</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="44" length="7"/><text>tacrine</text></annotation></passage></document>
<document><id>21543033</id><passage><infon key="DDI">No</infon><offset>0</offset><text>CONCLUSIONS: Coadministration of linagliptin did not alter the pharmacokinetics or pharmacodynamics of R- or S-warfarin, indicating that no dosage adjustment for warfarin is necessary when co-administered with linagliptin.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="162" length="8"/><text>warfarin</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="210" length="11"/><text>linagliptin</text></annotation></passage></document>
<document><id>21147720</id><passage><infon key="DDI">No</infon><offset>0</offset><text>The COPD patients had lower habitual energy-adjusted intakes of calcium, phosphorus and iron than controls, but not sodium.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="64" length="7"/><text>calcium</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="88" length="4"/><text>iron</text></annotation></passage></document>
<document><id>20857093</id><passage><infon key="DDI">No</infon><offset>0</offset><text>Paroxetine pretreatment inhibits CYP2D6 without inducing relevant changes in oxycodone exposure, and partially blunts the pharmacodynamic effects of oxycodone due to intrinsic pharmacological activities.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="0" length="10"/><text>paroxetine</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="149" length="9"/><text>oxycodone</text></annotation></passage></document>
<document><id>20201889</id><passage><infon key="DDI">No</infon><offset>0</offset><text>Atrial-selective sodium channel blockers, such as ranolazine and amiodarone, effectively suppress and/or prevent the induction of AF in experimental models, while producing little to no effect on ventricular myocardium.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="50" length="10"/><text>ranolazine</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="65" length="10"/><text>amiodarone</text></annotation></passage></document>
<document><id>22509280</id><passage><infon key="DDI">No</infon><offset>0</offset><text>In all these trials, we used either 1 mg/kg body weight of prednisone or 5 mg/kg body weight of prednisolone as positive controls to compare the efficacy of various test drugs.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="59" length="10"/><text>prednisone</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="96" length="12"/><text>prednisolone</text></annotation></passage></document>
<document><id>22414257</id><passage><infon key="DDI">No</infon><offset>0</offset><text>Patients with RA were under the supervision of rheumatologists; 15 of the patients with RA were being treated with methotrexate-sulfasalazine combined therapy, and two of the patients were being treated with leflunomid therapy.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="115" length="12"/><text>methotrexate</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="128" length="13"/><text>sulfasalazine</text></annotation></passage></document>
<document><id>21194340</id><passage><infon key="DDI">No</infon><offset>0</offset><text>Serum globulin concentration was lower on days 3 through 9, conjunctivitis histologic score was lower on day 14, herpetic DNA was shed less frequently throughout the study, goblet cell density was greater on day 21, and circulating anti-FHV-1 antibody concentration at study end was lower in famciclovir-treated cats, compared with these measurements in lactose-treated cats.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="292" length="11"/><text>famciclovir</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="354" length="7"/><text>lactose</text></annotation></passage></document>
<document><id>21274220</id><passage><infon key="DDI">No</infon><offset>0</offset><text>Non-pregnant women presenting to a family practice clinic with symptoms of lower urinary tract infection were randomly assigned to a single dose of one, two or three tablets of sulfadiazine/trimethoprim 410 mg/90 mg.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="177" length="12"/><text>sulfadiazine</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="190" length="12"/><text>trimethoprim</text></annotation></passage></document>
<document><id>22875632</id><passage><infon key="DDI">No</infon><offset>0</offset><text>Denosumab (a monoclonal antibody against RANK ligand) and toremifene (a selective estrogen receptor modulator) recently have been shown to be effective to reduce vertebral fractures in patients with non-metastatic prostate cancer receiving androgen-deprivation therapy.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="0" length="9"/><text>denosumab</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="58" length="10"/><text>toremifene</text></annotation></passage></document>
<document><id>19747807</id><passage><infon key="DDI">No</infon><offset>0</offset><text>Furthermore, a marked reduction in the activities of myocardial creatine kinase-MB (CK-MB) isoenzyme, lactate dehydrogenase (LDH), superoxide dismutase (SOD), catalase (CAT), and reduced glutathione (GSH) levels along with an increase in content of malondialdehyde (MDA) were observed.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="64" length="8"/><text>creatine</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="187" length="11"/><text>glutathione</text></annotation></passage></document>
<document><id>21327497</id><passage><infon key="DDI">No</infon><offset>0</offset><text>This was accompanied by significant increase of activities of three key gluconeogenic enzymes, namely phosphoenolpyruvate carboxykinase (PEPCK), fructose 1,6-biphosphatase (FBPase), and glucose 6-phosphatase (G6Pase) in liver and kidney by about twofold to threefold.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="102" length="19"/><text>phosphoenolpyruvate</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="145" length="8"/><text>fructose</text></annotation></passage></document>
<document><id>22119584</id><passage><infon key="DDI">No</infon><offset>0</offset><text>In addition, the National Malaria Control Programmes of these countries have virtually identical policies: (1) Artemisinin Combination Therapies (ACTs) for the treatment of symptomatic Plasmodium falciparum infection, (2) Long-Lasting Insecticide-treated bed Nets (LLINs) to reduce the Entomololgic Inoculation Rate (EIR), and (3) sulfadoxine-pyrimethamine for the Intermittent Preventive Treatment of malaria during pregnancy (IPTp).</text><annotation id="0"><infon key="type">DrugName</infon><location offset="331" length="11"/><text>sulfadoxine</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="343" length="13"/><text>pyrimethamine</text></annotation></passage></document>
<document><id>21247389</id><passage><infon key="DDI">No</infon><offset>0</offset><text>An old drug, Antabuse (disulfiram), used for decades in alcohol aversion therapy, and its metabolite Ditiocarb were shown from 1970s to suppress cancer growth in vivo and even in human patients.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="13" length="8"/><text>antabuse</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="23" length="10"/><text>disulfiram</text></annotation></passage></document>
<document><id>22870365</id><passage><infon key="DDI">No</infon><offset>0</offset><text>CONCLUSIONS: Propofol may decrease incidence of emergence agitation compared to sevoflurane in adults undergoing closed reduction of nasal bone fracture.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="13" length="8"/><text>propofol</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="80" length="11"/><text>sevoflurane</text></annotation></passage></document>
<document><id>20560365</id><passage><infon key="DDI">No</infon><offset>0</offset><text>METHODS: Obturator nerve block was performed in 37 cases by either nerve stimulation guide (NS group) or nerve stimulation and ultrasound guide (US group) with 10 ml of 1.5% lidocaine adding 1:200000 epinephrine.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="174" length="9"/><text>lidocaine</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="200" length="11"/><text>epinephrine</text></annotation></passage></document>
<document><id>23511357</id><passage><infon key="DDI">No</infon><offset>0</offset><text>CONCLUSION: Our data show a lower pain intensity and lower Rizatriptan intake at six-months follow-up with no adverse events in acupuncture patients compared to those treated with valproic acid.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="59" length="11"/><text>rizatriptan</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="180" length="8"/><text>valproic</text></annotation></passage></document>
<document><id>20352018</id><passage><infon key="DDI">No</infon><offset>0</offset><text>We have analyzed the actions of the specific serotonin reuptake inhibitor (SSRI) fluoxetine and the tricyclic agent desipramine (DMI) on wild-type and 5-hydroxytryptamine 1A receptor-null mutant (5-HT(1A)R KO) mice.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="81" length="10"/><text>fluoxetine</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="116" length="11"/><text>desipramine</text></annotation></passage></document>
<document><id>21652725</id><passage><infon key="DDI">No</infon><offset>0</offset><text>Repeated experience with sexually active males and concurrent treatment with estradiol and progesterone gradually increases female receptivity over the course of five trials to maximal levels.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="77" length="9"/><text>estradiol</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="91" length="12"/><text>progesterone</text></annotation></passage></document>
<document><id>23513501</id><passage><infon key="DDI">No</infon><offset>0</offset><text>BotuLinum toxin A (Botox, Allegan) is a potent neurotoxin that blocks the release of acetylcholine at the neuromuscular junction of cholinergic nerves.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="19" length="5"/><text>botox</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="85" length="13"/><text>acetylcholine</text></annotation></passage></document>
<document><id>22590838</id><passage><infon key="DDI">No</infon><offset>0</offset><text>In addition, mean doses of potassium and insulin demand as well as mean number of episodes of hyperglycemia, hypoglycemia and glucose levels out of the accepted range were significantly lower in insulin-metformin group (p &lt; 0.05).</text><annotation id="0"><infon key="type">DrugName</infon><location offset="27" length="9"/><text>potassium</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="203" length="9"/><text>metformin</text></annotation></passage></document>
<document><id>23382449</id><passage><infon key="DDI">No</infon><offset>0</offset><text>Removal of the somatostatin paracrine influence (Sst(-/-) mice or pretreatement with pertussis toxin) strongly increased glucagon release, did not prevent the glucagonostatic effect of G7, and unmasked a marked glucagonotropic effect of tolbutamide.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="211" length="8"/><text>glucagon</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="237" length="11"/><text>tolbutamide</text></annotation></passage></document>
<document><id>22324363</id><passage><infon key="DDI">No</infon><offset>0</offset><text>The platinum conjugated polymer showed high activity against A549, OVCAR3, and SKOV3 cancer cell lines exceeding the activity of carboplatin, but only the micelle based on the longest spacer had IC(50) values as low as cisplatin.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="129" length="11"/><text>carboplatin</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="219" length="9"/><text>cisplatin</text></annotation></passage></document>
<document><id>22274587</id><passage><infon key="DDI">No</infon><offset>0</offset><text>The simultaneous administration of doxorubicin and curcumin achieved the highest reversal efficacy and down-regulation of P-glycoprotein in MCF-7/ADR cell lines, an MCF-7 breast carcer cell line resistant to adriamycin.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="35" length="11"/><text>doxorubicin</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="208" length="10"/><text>adriamycin</text></annotation></passage></document>
<document><id>21614834</id><passage><infon key="DDI">No</infon><offset>0</offset><text>It has been demonstrated that ephedrone stimulates central nervous system and inhibits dopamine and norepinephrine re-uptake.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="87" length="8"/><text>dopamine</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="100" length="14"/><text>norepinephrine</text></annotation></passage></document>
<document><id>19955891</id><passage><infon key="DDI">No</infon><offset>0</offset><text>CONCLUSION: In conclusion, oral clonidine 3 microg/kg administered 90 minutes before induction of anesthesia attenuates the fall in MAP due to scalp infiltration with a dilute concentration of epinephrine-lidocaine solution in patients undergoing craniotomy under isoflurane anesthesia.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="205" length="9"/><text>lidocaine</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="264" length="10"/><text>isoflurane</text></annotation></passage></document>
<document><id>21376052</id><passage><infon key="DDI">No</infon><offset>0</offset><text>These findings support the prediction that exposure to shipping stress or LPS during puberty decreases behavioral responsiveness to estradiol and progesterone in adulthood in an outbred strain of mice through enduring suppression of ER-a expression in some brain areas involved in the regulation of female sexual behavior.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="132" length="9"/><text>estradiol</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="146" length="12"/><text>progesterone</text></annotation></passage></document>
<document><id>22507396</id><passage><infon key="DDI">No</infon><offset>0</offset><text>However, those allograft survivals were significantly lower than those patients positive for ACA (28%) alone (ACA vs. LMW heparin or Coumadin p=0.0001).</text><annotation id="0"><infon key="type">DrugName</infon><location offset="122" length="7"/><text>heparin</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="133" length="8"/><text>coumadin</text></annotation></passage></document>
<document><id>20385571</id><passage><infon key="DDI">No</infon><offset>0</offset><text>CONCLUSIONS: Under the study conditions, it was confirmed that sevoflurane and propofol have an additive effect on BIS, with no evidence suggesting the existence of a synergistic effect for the concentrations of both drugs typically used in clinical practice.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="63" length="11"/><text>sevoflurane</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="79" length="8"/><text>propofol</text></annotation></passage></document>
<document><id>20838771</id><passage><infon key="DDI">No</infon><offset>0</offset><text>After = 12 months of therapy, most patients who received raloxifene had PINP concentrations in the lower half of the premenopausal reference interval (58%), whereas among those who received alendronate, around 60% of patients had PINP concentrations below the lower limit of the premenopausal reference interval.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="57" length="10"/><text>raloxifene</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="190" length="11"/><text>alendronate</text></annotation></passage></document>
<document><id>19787010</id><passage><infon key="DDI">No</infon><offset>0</offset><text>RESULTS: The patient had dramatic improvement of pain and weakness after undergoing a fluoroscopically guided right L5 selective nerve root block with Depo-Medrol and Lidocaine.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="155" length="6"/><text>medrol</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="166" length="9"/><text>lidocaine</text></annotation></passage></document>
<document><id>19218991</id><passage><infon key="DDI">No</infon><offset>0</offset><text>Besides, the efficacy of intravitreal triamcinolone acetonide showed no significant differences compared with intravitreal bevacizumab but seemed to cause more adverse events than bevacizumab.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="38" length="13"/><text>triamcinolone</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="180" length="11"/><text>bevacizumab</text></annotation></passage></document>
<document><id>21548867</id><passage><infon key="DDI">No</infon><offset>0</offset><text>It has strong angiogenic potential, it acts protectively on endothelium, prevents and reverses thrombus formation after abdominal aorta anastomosis, affects many central disturbances (i.e., dopamine and 5-HT system), the NO-system (either L-arginine and L-NAME effects), endothelin, acts as a free radical scavenger (counteracting CCl4-, paracetamol-, diclofenac-injuries) and exhibits neuroprotective properties.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="190" length="8"/><text>dopamine</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="352" length="10"/><text>diclofenac</text></annotation></passage></document>
<document><id>20600909</id><passage><infon key="DDI">No</infon><offset>0</offset><text>Enoxaparin (Enox), a low molecular weight heparin, has been shown to lower brain amyloid beta (A beta) load in a mouse model for Alzheimer&amp;apos;s disease.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="0" length="10"/><text>enoxaparin</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="42" length="7"/><text>heparin</text></annotation></passage></document>
<document><id>22019650</id><passage><infon key="DDI">No</infon><offset>0</offset><text>RESULTS: 1 H-MRS studies revealed lower ratios of N-acetylaspartate (NAA)/Choline (Cho) and NAA/ Creatine (Cr) and higher ratios of Cho/Cr in patients with TBI when compared to the control group.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="74" length="7"/><text>choline</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="97" length="8"/><text>creatine</text></annotation></passage></document>
<document><id>23245537</id><passage><infon key="DDI">No</infon><offset>0</offset><text>However, although treatment with either bupropion or sertraline reduces the symptoms of depression, it may increase F2 isoprostane excretion.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="40" length="9"/><text>bupropion</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="53" length="10"/><text>sertraline</text></annotation></passage></document>
<document><id>23614971</id><passage><infon key="DDI">No</infon><offset>0</offset><text>The addition of fentanyl alone to bupivacaine may reduce this effect.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="16" length="8"/><text>fentanyl</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="34" length="11"/><text>bupivacaine</text></annotation></passage></document>
<document><id>20560295</id><passage><infon key="DDI">No</infon><offset>0</offset><text>NAC slows the rate of decline of lung function in idiopathic pulmonary fibrosis (IPF) patients concurrently treated with prednisone and azathioprine.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="121" length="10"/><text>prednisone</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="136" length="12"/><text>azathioprine</text></annotation></passage></document>
<document><id>20339913</id><passage><infon key="DDI">No</infon><offset>0</offset><text>The relative dose intensity was lower with sunitinib than capecitabine (73 vs. 95%).</text><annotation id="0"><infon key="type">DrugName</infon><location offset="43" length="9"/><text>sunitinib</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="58" length="12"/><text>capecitabine</text></annotation></passage></document>
<document><id>21378544</id><passage><infon key="DDI">No</infon><offset>0</offset><text>Cases involving the cervix or lower uterine segment were confirmed as endometrial in origin based on immunohistochemical stains (estrogen receptor, progesterone receptor, p16, and vimentin).</text><annotation id="0"><infon key="type">DrugName</infon><location offset="36" length="7"/><text>uterine</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="148" length="12"/><text>progesterone</text></annotation></passage></document>
<document><id>20869883</id><passage><infon key="DDI">No</infon><offset>0</offset><text>CONCLUSIONS: Thoracic epidural anesthesia with either levobupivacaine or bupivacaine provided comparable sensory block features, intraoperative hemodynamics, and postoperative analgesia for thoracic surgery.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="54" length="15"/><text>levobupivacaine</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="73" length="11"/><text>bupivacaine</text></annotation></passage></document>
<document><id>22521583</id><passage><infon key="DDI">No</infon><offset>0</offset><text>In conclusion, chronic nicotine exposure attenuates short-term synaptic plasticity, and the observed synaptic defects might be a consequence of loss of estradiol-17ß-signaling.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="23" length="8"/><text>nicotine</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="152" length="9"/><text>estradiol</text></annotation></passage></document>
<document><id>22721833</id><passage><infon key="DDI">No</infon><offset>0</offset><text>If a controlled exposure system with a single chemical in pure water is a reasonable representation of the environment, then the use of ketoprofen is likely to pose a lower risk for wild fish than diclofenac, but if bioconcentration factors from effluent-exposed fish are applied, the risks may be more similar.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="136" length="10"/><text>ketoprofen</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="197" length="10"/><text>diclofenac</text></annotation></passage></document>
<document><id>20738777</id><passage><infon key="DDI">No</infon><offset>0</offset><text>Refractory ascites: can it be defined only by the response to furosemide and spironolactone?</text><annotation id="0"><infon key="type">DrugName</infon><location offset="62" length="10"/><text>furosemide</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="77" length="14"/><text>spironolactone</text></annotation></passage></document>
<document><id>22075224</id><passage><infon key="DDI">No</infon><offset>0</offset><text>Moreover, the inability of salicylate to prevent neomycin-induced ototoxicity implies possible differences between the mechanisms of auditory hair cell loss induced by gentamicin and neomycin.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="168" length="10"/><text>gentamicin</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="183" length="8"/><text>neomycin</text></annotation></passage></document>
<document><id>21929645</id><passage><infon key="DDI">No</infon><offset>0</offset><text>Whether or not a cyclosporine A (CsA)-free immunosuppressant regimen based on sirolimus (SRL) prevents aortic stiffening and improves central hemodynamics in renal recipients remains unknown.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="17" length="12"/><text>cyclosporine</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="78" length="9"/><text>sirolimus</text></annotation></passage></document>
<document><id>22674269</id><passage><infon key="DDI">No</infon><offset>0</offset><text>The effective block by quinidine on synaptic currents as well as nonliganded openings points to dual sources for the calcium-dependent myopathy in certain forms of SCS.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="23" length="9"/><text>quinidine</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="117" length="7"/><text>calcium</text></annotation></passage></document>
<document><id>23078554</id><passage><infon key="DDI">No</infon><offset>0</offset><text>Ethosuximide reduces ethanol withdrawal-mediated disruptions in sleep-related EEG patterns.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="0" length="12"/><text>ethosuximide</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="21" length="7"/><text>ethanol</text></annotation></passage></document>
<document><id>20421396</id><passage><infon key="DDI">No</infon><offset>0</offset><text>Consistent with susceptibility testing, the T237A variant demonstrated a lower k(cat)/K(m) for imipenem, cephalothin, and cefotaxime; interestingly, the most dramatic reduction was with cefotaxime.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="95" length="8"/><text>imipenem</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="186" length="10"/><text>cefotaxime</text></annotation></passage></document>
<document><id>20352091</id><passage><infon key="DDI">No</infon><offset>0</offset><text>Here we studied short- and long-term effects of clarithromycin and metronidazole treatment, a commonly used therapy regimen against H. pylori, on the indigenous microbiota in the throat and in the lower intestine.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="48" length="14"/><text>clarithromycin</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="67" length="13"/><text>metronidazole</text></annotation></passage></document>
<document><id>19357643</id><passage><infon key="DDI">No</infon><offset>0</offset><text>3,4-Diaminopyridine enhances the release of acetylcholine at the neuromuscular synapse, and pyridostigmine inhibits the degradation of this neurotransmitter.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="44" length="13"/><text>acetylcholine</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="92" length="14"/><text>pyridostigmine</text></annotation></passage></document>
<document><id>23235923</id><passage><infon key="DDI">No</infon><offset>0</offset><text>While AT1R signaling suppresses the influence of corticotropin on the generation of cyclic adenosine monophosphate, the expression of the AT1R and its associated enzyme activities are under the control of glucocorticoids.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="49" length="13"/><text>corticotropin</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="91" length="9"/><text>adenosine</text></annotation></passage></document>
<document><id>21422379</id><passage><infon key="DDI">No</infon><offset>0</offset><text>In 10 healthy young humans (5 men), we used bolus injections of sodium nitroprusside and phenylephrine hydrochloride to drive transient decreases and increases in blood pressure, respectively, to quantify cardiac baroreflex sensitivity to falling and rising blood pressure.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="71" length="13"/><text>nitroprusside</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="89" length="13"/><text>phenylephrine</text></annotation></passage></document>
<document><id>19470140</id><passage><infon key="DDI">No</infon><offset>0</offset><text>Post-operative analgesia consisted of intercostal nerve blocks with bupivacaine, CRIs of fentanyl (2-5 microg kg(-1) hour(-1)) and lidocaine (40 microg kg(-1) minute(-1)) and with oral meloxicam (0.1 mg kg(-1)).</text><annotation id="0"><infon key="type">DrugName</infon><location offset="131" length="9"/><text>lidocaine</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="185" length="9"/><text>meloxicam</text></annotation></passage></document>
<document><id>21814800</id><passage><infon key="DDI">No</infon><offset>0</offset><text>The pharmacokinetics-pharmacodynamics (PK-PD) breakpoint of piperacillin/tazobactam (PIPC/TAZ) for hospital-acquired pneumonia (HAP) and Pseudomonas aeruginosa-induced bacteremia is controversial, since the susceptibility of P. aeruginosa to PIPC/TAZ is known to be lower than that set by the Clinical Laboratory Standards Institute (CLSI), =64 mg/L.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="60" length="12"/><text>piperacillin</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="73" length="10"/><text>tazobactam</text></annotation></passage></document>
<document><id>22923355</id><passage><infon key="DDI">No</infon><offset>0</offset><text>Three compounds, dabigatran, rivaroxaban, and apixaban, are now challenging this well established prescription, as they showed similar effect in preventing thromboembolism with a lower bleeding rate in recently published well designed, controlled randomised, non-inferiority trials.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="29" length="11"/><text>rivaroxaban</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="46" length="8"/><text>apixaban</text></annotation></passage></document>
<document><id>22668972</id><passage><infon key="DDI">No</infon><offset>0</offset><text>In vivo, sphingosine kinase 1 deletion prevents and etanercept (2-week treatment initiated 6 weeks after myocardial infarction) reverses the reduction of cerebral blood flow, without improving cardiac function.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="9" length="11"/><text>sphingosine</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="52" length="10"/><text>etanercept</text></annotation></passage></document>
<document><id>22806306</id><passage><infon key="DDI">No</infon><offset>0</offset><text>CONCLUSIONS: The RDIs of vincristine and cyclophosphamide in the maintenance phase were significantly lower than that in children.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="25" length="11"/><text>vincristine</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="41" length="16"/><text>cyclophosphamide</text></annotation></passage></document>
<document><id>19203797</id><passage><infon key="DDI">No</infon><offset>0</offset><text>At the end of the experiment, V5dipic-NH(2) statistically significantly reduced the levels of blood glucose (P&lt;0.01), serum total cholesterol (P&lt;0.01), triglycerides (P&lt;0.01) and the activities of serum aspartate amino transferase (P&lt;0.05) and alkaline phosphatase (P&lt;0.01) compared to untreated diabetic animals.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="244" length="20"/><text>alkaline phosphatase</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="130" length="11"/><text>cholesterol</text></annotation></passage></document>
<document><id>23353805</id><passage><infon key="DDI">No</infon><offset>0</offset><text>Here we describe polymersomes able to encapsulate up to 6% (w/w) of doxorubicin (DOX) together with 30% (w/w) of superparamagnetic iron oxide nanoparticles (USPIO; ?-Fe2O3).</text><annotation id="0"><infon key="type">DrugName</infon><location offset="68" length="11"/><text>doxorubicin</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="131" length="4"/><text>iron</text></annotation></passage></document>
<document><id>23313443</id><passage><infon key="DDI">No</infon><offset>0</offset><text>We describe a case of deep vein thrombosis in a 43-year-old man with lepromatous leprosy who was being treated with thalidomide and prednisone for a type 2 leprosy reaction (erythema nodosum leprosum); the patient also had transiently positive antiphospholipid antibody results.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="116" length="11"/><text>thalidomide</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="132" length="10"/><text>prednisone</text></annotation></passage></document>
<document><id>22092926</id><passage><infon key="DDI">No</infon><offset>0</offset><text>MATERIALS AND METHODS: An extensive literature search was performed to describe the pharmacologic actions of imiquimod, 5-FU, and diclofenac.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="109" length="9"/><text>imiquimod</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="130" length="10"/><text>diclofenac</text></annotation></passage></document>
<document><id>22074122</id><passage><infon key="DDI">No</infon><offset>0</offset><text>CONCLUSIONS: Despite similar BP lowering effect, aliskiren, but not amlodipine, reduced QT duration and dispersion, which might be related to the ability of aliskiren to interfere with mechanisms underlying myocardial electrical instability in the heart of diabetic hypertensive patients.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="68" length="10"/><text>amlodipine</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="157" length="9"/><text>aliskiren</text></annotation></passage></document>
<document><id>22552908</id><passage><infon key="DDI">No</infon><offset>0</offset><text>Mean BA-Z scores were lower in females (P = 0.02), Caucasians (P = 0.006), Tanner stage 1-3 children (P = 0.004), and patients with colonic disease (P = 0.0006), past corticosteroid exposure (P = 0.01), current azathioprine/6-mercaptopurine treatment (P = 0.003), or lower height (P = 0.006), weight (P &lt; 0.001), or body mass index (BMI) (P = 0.01) CA-Z scores.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="211" length="12"/><text>azathioprine</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="226" length="14"/><text>mercaptopurine</text></annotation></passage></document>
</collection>
